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LIST OF ABBREVIATIONS  
 
ADP Atomic Displacement Parameter 
ADPRP 2'-monophosphoadenosine-5'-diphosphoribose 
APS  Advanced Photon Source 
AR Aldose Reductase 
CBL Calcium Binding Loop 
CBR Calcium Binding Region 
CC Correlation Coefficient 
CCD Charge Coupled Device 
CGLS Conjugate Gradient Least Squares 
CSD Cambridge Structures Database 
DDT  Dichlorodiphenyltrichloroethane 
DOC2 Double C2-like domain-containing proteins 
ESD Estimated Standard Deviation  




LS Least Squares 
MAD Multiple Wavelength Anomalous Diffraction 
MIR Multiple Isomorphous Replacement 
MR Molecular Replacement 
NADPH Dihydro-nicotinamide-adeninde-dinucleotide-
phosphate 
NCS Non-Crystallographic Symmetry 
NMR Nuclear Magnetic Resonance 
NPD Non Positive Definite 







PKC Protein Kinase C 
R.M.S.D. Root Mean Standard Deviation 
SAD Single Wavelength Anomalous Diffraction 
SIR Single Isomorphous Replacement 
SM Sec1/Munc18-like protein 
SNAP Synaptosome-Associated Protein of 25 kDa 
SNARE Soluble N-ethylmaleimide-Sensitive Factor 
Attachment Protein Receptor 
SV2 Synaptic vesicle proteins 2a 
TLS Translation, Libration, Screw motion 































Asp Aspartic acid 
Cys Cysteine 
Gln Glutamine 






















Pictures containing molecular graphics were created with the programs BOBSCRIPT 
(Esnouf 1997), PYMOL (DeLano 2002) and COOT (Emsley et al. 2004). Some of the 
pictures were rendered with the program RASTER3D (Merritt et al. 1997). 
 
Fig. 3.20 and 4.8 were made using the PARVATI webserver 
(http://www.bmsc.washington.edu/parvati; (Merritt 1999)). 
 
Fig. 4.19B and 4.20 were created with the program DELPHI (Honig et al. 1995) and 
PYMOL. 
 









The high resolution (0.82 Å) structure of Aldose Reductase (an enzyme implicated in 
the polyol pathway) is presented. The aim of the work was a careful inspection of the 
model with particular attention to features visible at high resolution. Atomic resolution 
data allowed to model more multiple conformations than in the previously determined 
structure and to improve the fit between model and data. Particular attention was paid to 
the examination of the list of disagreeable restraints: some of them are probably due to 
wrong restraints while others are real features of the structure observable only at high 
resolution. These observations should be used both to build a new library of restraints and 
to explain in more details the molecule structure and function. The most interesting 
feature of this model is the safety-belt loop modeled in two discrete conformations: the 
common closed and a partially open conformation (possible because the holo-enzyme is 
in a post-reaction state). The removal of one interaction is enough to trigger the release of 
the cofactor and to let the safety-belt loop open. Accurate inspection of various Aldose 
Reductase high resolution structures reveals a domain movement that has been called 
"tongs movement": loops at the top and at the bottom are closer to or farther away from 
each other while the β-barrel is rigid. This movement could be related to the post reaction 
state of the molecule and to the release of the cofactor.  
The crystal structure of the Ca2+-free form of the C2A domain of Rabphilin3A (a 
neuronal protein involved in the synaptic vesicle cycle for which the exact biological role 
still remains to be elucidated) to a resolution of 1.92 Å is presented. It has a type I 
topology and the structure is characterized by an eight-stranded antiparallel β-sandwich. 
Its electrostatic surface is highly basic and similar to the one of the C2B domain of 
Rabphilin3A. In the C2A domain of Rabphilin3A two specific structural features related 
to deviations from the consensus sequence were found: a different position of the calcium 
binding loop 1 (CBL1) that causes a significant shift of the conserved Ca2+ binding 






localized negative patch close to the calcium binding region. The structure presents new 
features with respect to other C2 domains suggesting a new function for this domain.  
In the last chapter tests of a new version of SHELXL (Sheldrick et al. 1997), in which 
a restraint applied to anisotropic displacement parameters was implemented (DELU 
restraint) are presented. The new restraint mimics a TLS refinement and it should be 
useful at medium resolution (1.5-2.0 Å). Comparisons between structures refined at 
various resolutions both with TLS refinement in REFMAC and with two versions of 
SHELXL were carried out. The results show that at medium resolution the two programs 
are comparable. The new restraint is, however a large improvement compared to the old 
version of SHELXL. 
 





2 Theoretical background 
 
2.1 X-ray crystallography  
The aim of X-ray crystallography is to resolve the three dimensional structure of 
molecules. Because atoms are separated by distances in the range of Ångstroms it is 
mandatory to use X-rays which have wavelengths of 0.1-100 Å. 
X-rays can be described as an electromagnetic wave that interacts with the electron cloud 
that surrounds the atoms. When electrons get hit by X-rays they emit radiation that has 
the same frequency of the incident beam (elastic scattering) or a different one (inelastic 
scattering).  
The atomic scattering factor of a single atom can be described by the equation:  
 ( ) [ ] rdSri2exprf
r
aa ∫ ⋅πρ=   2.1 
where ( )raρ  is the electron density (approximated to be spherical) of an atom at position 
r  and S  is the scattering vector. The atomic scattering factor is function of λ 
(wavelength of the incident beam) and θ (half of the diffraction angle) because it depends 





sin2S  2.2  
Because the result of an X-ray experiment is an average in space and time the atoms can 











2sinBexpT  2.3 
where B=8π2<u2> is the atomic displacement parameter (isotropic or anisotropic) and u is 
the square mean displacement of the atom. Consequently the atomic scattering factor can 












sinBexpf'f  2.4 





The radiation emitted by the whole crystal is the summation of waves each scattered by 
one electron. Positive interference takes place when the phase shift of the waves is an 
integer multiple of 2π and this phenomenon is described by Bragg's law (Fig. 2.1): 
 λ=θ nsind2  2.5 
The structure factor for the crystal is then the summation of the atomic scattering factors 
over all the j atoms of the unit cell: 
 ( ) [ ]∑ ⋅π=
j
jj Sri2expfSF  2.6 
or considering the electron cloud around the atoms: 
 ( ) ( ) [ ]∫ ⋅πρ=
cell
dVSri2exprSF  2.7 
The structure factor F  can also be expressed in terms of fractional coordinates (x, y, z) 
and Bragg indices (h, k, l), which describe the lattice planes that cause the diffraction: 









dxdydzlzkyhxi2expxyzV)hkl(F  2.8 
The structure factor is the Fourier transform of the electron density and viceversa. 
Therefore the electron density can be written as: 




1xyz  2.9 
The structure factor F  is a vector that can be expressed also as: 









Figure 2.1 The two lattice planes are separated by the distance d. The X-rays are reflected by the 
planes with an angle Θ. 





and the electron density as: 




1xyz  2.11 
 
2.2 The phase problem 
In an X-ray experiment it is only possible to measure spot intensities that are 
proportional to the square of the amplitudes of the structure factors: 
( ) ( ) 2hklFhklI ∝  2.12 
while the phases that contain the most important information can be obtained only 
indirectly: this is the so called phase problem. 
In macromolecular crystallography phases can be estimated by different approaches like: 
a) Isomorphous replacement (MIR) 
b) Anomalous diffraction (MAD, SAD) 
c) Molecular replacement (MR) 
d) Direct methods 
 
2.2.1 Isomorphous replacement 
With the isomorphous replacement method the presence of heavy atoms in 
crystals is used to get initial phases. Heavy atoms are introduced in the crystals by 
soaking them in solution containing the heavy atoms or by cocrystallization. The only 
difference between native and derivative crystals should then be the presence of the 
heavy atoms (hence the name isomorphous replacement). Therefore the structure factor 
of the derivatives can be written as: 
PHPH FFF +=  2.13 
where PF  is the structure factor of the native protein and HF  the contribution of the heavy 
atom. Practically intensities of native crystals and of one or more derivatives are 
collected. The differences between derivative and native structure factors are then used 
for phasing: 





( )2PPH2H FFF −=  2.14 
The positions of the heavy atoms are found by examination of Patterson maps. 
Graphically a multiple isomorphous replacement (MIR) can be describes as in Fig. 2.2 
where it can be seen that the phase can be unambiguously determined if two or more 
derivatives are available. On the contrary in case of single isomorphous replacement 
(SIR) there is a two fold phase ambiguity. The major problem of this technique is that 















Figure 2.2 Harker construction of the MIR method. The black circle with radius 
PF  represents 
the native crystal with unknown phases. The light blue circle with radius 
1PHF  represents the first 
derivative with unknown phases. The vector 1HF  (depicted in magenta) is calculated from the 
heavy atom position obtained by inspection of the Patterson map. The intersections of the two 
circles define the two possible values for the phase of the native crystal (SIR). If a second 
derivative is available (red circle) the three circles intersect in a single point that defines the only 
possible value of the native crystal phase. 





2.2.2 Anomalous dispersion 
In SAD (Single Wavelength Anomalous Diffraction) and MAD (Multiple 
Wavelength Anomalous Diffraction) experiments the anomalous scattering of particular 
atoms present in the crystal is used to derive the phases of the protein. When the 
frequency of the X-rays is near the absorption edge of an element, an electron is ejected 
from the core of the atom and a photon can be absorbed: electrons from higher energy 
shells decay to lower energy ones emitting a photon with lower energy (fluorescence). 
The atomic scattering factor of an anomalous scatterer can be then described as: 
( ) ( )λ+λ+= "if'fff 0ano  2.15 
where f0 is the normal scattering factor contribution, 'f  is the dispersive signal and ''f  is 
the anomalous signal. ''f  can be measured by fluorescence spectroscopy while 'f  can be 
calculated from ''f  by the Kramers-Kronig equation (Fig. 2.3): 






'E"f'E2E'f  2.16 
The result of anomalous dispersion is that Friedel's law breaks down: 





Figure 2.3 Theoretical absorption edges and values of f' and f'' for Selenium and Bromine 
(http://www.bmsc.washington.edu/scatterer). 





The amplitudes of structure factors containing an anomalous scatterer are (Hendrickson 
et al. 1985): 






obs  2.18 
where TF  is the total structure factor, AF  the contribution of the anomalous scatterer,       
a = ( ''f 2+ 'f 2)/f02, b = 2 'f /f0, c = 2 ''f /f0 and α = φT - φA. 
Experimentally the Bijvoet differences are measured (Fig. 2.4): 
lkhhklano FFF −−−−≈Δ  2.19 
and because in a MAD experiment anoFΔ s are measured at least at two different 
wavelengths, TF , AF  and α can be extracted.  
On the contrary in a SAD experiment some approximations have to be made: 
( )−+ +≈ FF
2
1FT  2.20 
 ( )−+ −≈α FF
2
1sinFA  2.21 
If +F >> −F  than addition of α = 90° to the phase of AF  is a good approximation of 
TF , if 
+F << +F  than addition of α = 270° to the phase of AF  is a good approximation 
of TF  and if 












Figure 2.4 Argand diagram of a structure with significant anomalous signal. The diagram 
illustrates the origin of the inequality of phase and amplitude for the resulting structure factors +F  
and −F  and consequently the origin of the Bijvoet differences. 





2.2.3 Molecular replacement 
The structure of a related protein (determined either by X-ray 
crystallography or by NMR) with a sequence homology of at least 40%, can be used in 
molecular replacement as search model for providing initial estimated phases of the 
unknown structure. The information contained in the known structure has to be 
transferred to the crystal of the unknown protein: a proper orientation (described by three 
angles) and a proper translation (described by three translation parameters) have to be 
found. For doing that the Patterson function, which is the Fourier transform of the 
intensities and which can have phases only equal to 0° or 180° is calculated: 





1uvwP  2.22 
where u, v and w are relative coordinates in the unit cell. The rotation function R, used to 
find the right orientation, is the result of the maximum overlap between two self-
Patterson functions: 
( ) ( ) ( )∫=αβγ
U
calcobs uduxPuPR  2.23 
where U is the volume of the Patterson map, P is the Patterson map value at point u  and 
α, β and γ are the three rotation Euler angles.  
Once the orientation has been fixed, the right position in the unit cell is described by the 
translation function T: 
( ) ( ) ( )∫=
U
obscalczyx uduxPt,uPtttT  2.24 
This function is optimized via a trial-error procedure: after each trial the calculated 
structure factors ( calcF ) are compared with the observed ones ( obsF ) and an R value or a 
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where hklF is the average structure factor amplitude over the reflections. 
Most of the molecular replacement programs use a two steps procedure in which first a 
rotation function search is performed, followed by a translation function search. In the 
last years a six-dimensional search where all the orientations and translations are checked 
simultaneously, due to progress in the computer field, has become possible. 
 
2.2.4 Direct methods 
Direct methods are statistical methods that use probabilistic relationships 
between the phases. With the assumption that the electron density in a structure is 




'hh'hh FFqF  2.27 
where q is a constant dependent on sinθ/λ for the reflection h(hkl). Because the atomic 
scattering factors are dependent on the diffraction angles θ, the amplitudes F  of 
reflections measured at different angles cannot be compared with each other directly and 
the use of normalized structure factors E  instead of F  is recommended. 
From the Sayre's equation the so-called triple phase relation can be extracted: 
'hh'hh −φ+φ≈φ  2.28 
This relationship is true in a probabilistic sense and its probability function can be written 














expgP  2.29 





where g is a normalizing factor, 'hh'hh −φ−φ−φ=Φ  and N the number of atoms present 
in the structure. It is easy to see that direct methods are more successful for structures 
with a limited number of atoms. 
Phases of non-centrosymmetric structures can be derived using the tangent-formula 




















in which the summation is carried out over all relevant triplets.  
For the solution of macromolecular structures dual-space recycling is used (Miller et al. 
1993): a starting set of random atoms is generated, the corresponding structure factors are 
calculated, phases are refined and an electron density map is generated. Peaks are 
searched in the map and a list of new atoms is made. The whole process is repeated over 















Figure 2.5 Dual-space recycling (Shake-and-Bake procedure) as implemented in SHELXD. 





2.3 Density modification 
The phases obtained experimentally or by molecular replacement are generally 
not very accurate. They can be improved by iterative density modification cycles. Density 
modification techniques use some conserved features of correct electron density maps to 
improve the observed map. Density modification is normally carried out in a two steps 
procedure: first the electron density map obtained experimentally is modified in real 
space in such a way that it is consistent with the expectations and then phases are 
calculated from this modified map and combined with the experimental ones to form a 
new set of phases. The major problem of this approach is how to weight the observed 
phases with the ones obtained from the modified map. The most common approaches 
used for density modification are solvent flattening, histogram matching, NCS averaging, 
maximum-likelihood density modification and the sphere of influence method. 
Solvent flattening: Protein crystals contain often a large amount of solvent (30 to 
80%). Only a small amount of solvent molecules is ordered in the crystal while the 
majority of the molecules form a disordered continuum. As result the solvent electron 
density map is evenly distributed and consequently can be flatted down so to emphasize 
the protein electron density that has higher average value and higher variance. In the 
Wang method (Wang 1995) a three dimensional grid is placed in the asymmetric unit of 
the cell. Around each grid point the standard deviation σ(ρ) of the electron density is 










=ρσ  2.31 
where ρi is the individual electron density at the grid point i, ρ  is the average electron 
density in the sphere and N is the total number of grid points. The calculated σ values are 
ranked by height and divided into two groups corresponding to the percentage of solvent 
and protein in the cell. The points of the group with lower values of σ are considered as 
solvent and the density of them is set to a constant low value so that the noisy peaks are 
removed and the density distribution becomes flat. 





 Histogram matching: It takes into account features of the protein and can 
therefore be considered complementary to solvent flattening. The ideal electron density 
histogram of a protein does not depend on the structural conformation but it is influenced 
by the overall temperature factor, the resolution and the phase error (Zang et al. 2001). If 
resolution and overall temperature factor are known one can improve the phases by 
histogram matching. This technique can also be used for phase extension.  
 NCS averaging (Vellieux et al. 1997): This method is used when there are 
molecules in the unit cell related by non-crystallographic symmetry (NCS). In that case 
the electron density of NCS-related molecules is assumed to be similar and can thus be 
averaged. In this way density errors are minimized and phases can be improved after re-
inversion of the map. Both NCS rotation matrix and protein density mask, which 
describes the shape of the electron density of a single molecule, have to be determined.  
 Maximum-likelihood density modification (Terwilliger 2000): The basic idea of 
this method is that there are two kinds of information needed for density modification. 
Information coming from experimental phases and amplitudes are used to calculate the 
probability distribution of the structure factors while the likelihood of a map resulting 
from the structure factors is used to determine the probability distribution of the map. 
Taking into account also the environment of different points in the map (histogram-based 
approach) and combining the two probabilities just described, a total likelihood is 
maximized. This idea is implemented in the program RESOLVE (Terwilliger 2000). 
 Sphere of influence method (Sheldrick 2002): In the sphere of influence method 
the variance of the density over the surface at a sphere of radius 2.42 Å (corresponding to 
1,3-interatomic distance in macromolecules) is calculated. Pixels with the smallest 
variance are assigned to the solvent, pixels with the highest one to the boundary region 
and the rest to the protein region. The use of a crossover region allows to avoid that 
density modification will be locked into an initial poor solvent boundary. 
 






In most cases the model built manually or automatically in the electron density 
map obtained after density modification is incomplete and partially wrong. Iterative 
model building via inspection of electron density map and cycles of refinement should 
increase the agreement between observed and calculated data. The agreement can be 










R  2.32 
In macromolecular crystallography an additional index Rfree (Brunger 1992) is used for 
cross-validation and to avoid overfitting: a small percentage of the data (normally around 
5%) are not used in refinement and their agreement with the refined data is monitored.  
A model is described by atomic coordinates and by atomic displacement parameters that, 
depending on the resolution and consequently on the data-to-parameter ratio, can be 
modeled as isotropic, anisotropic or via TLS. The data-to-parameter ratio can be 
artificially increased using constraints or restraints. The first are exact mathematical 
conditions that decrease the number of parameters while the second are additional 
observational equations that increase the number of data. More details about high 
resolution refinement and restraints are discussed in Chapters 3 and 5 respectively.  
Basically there are two different mathematical approaches that are used in the refinement 
of macromolecules: least-squares and maximum likelihood. 
In the least-squares method the observations (experimental intensities) have fixed values 
and the parameters are varied in such a way that the calculated values approach the 
observed ones as closely as possible. In the program SHELXL (Sheldrick et al. 1997) the 






obshkl FFwQ  2.33 
where hklw  is a weighting factor by which less accurate structure factors are down 
weighted. This method is usually too expensive for macromolecules for which the 
conjugate gradient solution of the sparse least squares normal equations (Tronrud 1992) 





is often used. This kind of refinement works well only for models with very small errors 
and for which high resolution data are available.  
In the maximum-likelihood method (implemented in the program REFMAC (Murshudov 
et al. 1997)) the theoretical approach is different. Given the model the probability 
function that a set of data would be observed is calculated. This can be described as: 
( )∏=
i
calc,iobs,i F;FPL  2.34 
where ( )calc,iobs,i F;FP  is the probability distribution of the structure factor obs,iF  given the 
model structure factor calc,iF  (Pannu et al. 1996). For computational reasons the logarithm 
of the likelihood function is calculated and minimized. 
 





3 Aldose Reductase 
 
3.1 Introduction 
In this chapter the crystal structure of the holo-enzyme human Aldose Reductase will 
be presented. This enzyme, implicated in the polyol pathway, has been the object of 
different studies of drug design and structures with different inhibitors have already been 
solved. The aim of the work was a careful investigation of the model with particular 
attention to the features characteristic of high resolution refinement like disordered 
residues, clusters of disordered parts of the molecule, hydrogen bond networks, 
anisotropic temperature factors, calculation of estimated standard deviations and accurate 
examination of disagreeable restraints.  
 
3.1.1 Aldose Reductase 
Human Aldose Reductase (AR; EC 1.1.1.21) is a member of the aldo-
ketoreductase superfamily and catalyzes the NADPH-dependent reduction of a wide 
variety of aldehydes to their corresponding alcohols. It is implicated in the polyol 
pathway converting glucose to sorbitol, which is then transformed into fructose by 
sorbitol dehydrogenase (Fig. 3.1). The increasing level of glucose through the polyol 
pathway induces biochemical imbalances in some tissues and leads to diabetic 
complications such as the development of glaucoma, retinopathies and cataract 
(Kinoshita et al. 1988; Yabe-Nishimura 1998; Costantino et al. 1999; Dunlop 2000). In 
vitro and in vivo studies suggest that a high level of sorbitol can be avoided by inhibition 
of Aldose Reductase. Inhibitors of AR thus represent promising targets for the 
development of new drugs (Costantino et al. 2000; El-Kabbani et al. 2004b; Klebe et al. 
2004; Petrash 2004; Podjarny et al. 2004). 
 






Human Aldose Reductase consists of 316 residues, weights 36 kDa and the crystals have 
a 43% solvent content. It folds as an eight-stranded β/α barrel with a small β-sheet on the 
N-terminus (residues 2-14) and a C-terminal extension (residues 275-315). The active site 
is located on the C-terminus of the barrel and the NADP+-binding site is near the 
hydrophobic active site pocket (Urzhumtsev et al. 1997; El-Kabbani et al. 1998). The 
catalytic residues of the active site are Lys77, His110 and Tyr48 (which most likely acts 
as proton donor, (Bohren et al. 1994)) together with the nicotinamide moiety of the 
cofactor NADPH. The active site can be divided into a rigid invariant region called anion 
binding pocket (residues Trp20, Val47, Tyr48, Trp79, His110) where the residues are 
interacting with the negatively charged part of the inhibitor (Harrison et al. 1994; Klebe 
et al. 2004; Sotriffer et al. 2004); in a quite flexible part (induced-fit phenomena) called 
specificity pocket (residues Thr113, Phe115, Phe122, Cys303, Tyr309) where the 
residues are interacting with only some of the inhibitors (El-Kabbani et al. 2004a; 
Howard et al. 2004; Ruiz et al. 2004; Steuber et al. 2006), and in a very flexible part 
formed by the strand between Val297 and Leu300. 
A variety of compounds that inhibit Aldose Reductase have been investigated for many 
years. Inhibitors of AR can be divided into four major classes (Miyamoto 2002): 
- hydantoin type inhibitors 
- new sulfonyl-pyridazinone type inhibitors 
- carboxylic acid type inhibitors 







NADPH NADP+ NAD+ NAD  
 
Figure 3.1 Polyol pathway showing the chemical reactions and the enzymes involved in the 
transformation of glucose into fructose via sorbitol. 





Hydantoin type inhibitors (Fig. 3.2A), like Sorbinil, Fidarestat and Minalrestat, have a 
pKa value of about 8 and they can easily cross the membrane. Unfortunately Sorbinil 
induces hypersensitivity reactions, through toxic intermediate (Spielberg et al. 1991). 
On the contrary, due to their low pKa, carboxylic acid type inhibitors (Fig. 3.2B) are 
ionized under physiological conditions and they can hardly cross the membrane (Krentz 
et al. 1992). The structure of the inhibitor IDD594 is presented in Appendix A. 
Recent studies on phenylsulphonylnitromethanes (Fig. 3.2C) show that these compounds 
too are AR inhibitors.  
In 2003 a new class of inhibitors with excellent properties was proposed (Fig. 3.2D, 
 
 
Figure 3.2 Some structures of different AR inhibitors. A) Hydantoin type inhibitors. B) 
Carboxylic acid type inhibitors. C) Arylsulphonylnitromethanes inhibitor. D) Novel sulfonyl-
pyridazone inhibitor. 





(Mylari et al. 2003)). It is a non-carboxylic, non-hydantoin inhibitor with good in vivo 
efficiency and almost perfect bioavailability. 
 The mechanism of the forward-reaction catalyzed by Aldose Reductase can be 
described as a sequential ordered mechanism in which NADPH binds first, followed by 
the binding of the substrate (Kubiseski et al. 1992). Once the aldehyde has been 
converted into the corresponding alcohol, the product is released and only then is the 
oxidized cofactor disengaged. Before crystal structures were determined, kinetic studies 
already showed that the cofactor up-take and release are accompanied by a 
conformational change of the enzyme*cofactor complex (Kubiseski et al. 1992). The 
conformational change of the protein upon NADPH binding was confirmed monitoring 
via spectroscopic fluorescence the quenching of the protein (that contains 6 Trp residues) 
and a reaction scheme with a fast bimolecular ligand-protein association followed by a 
unimolecular protein isomerization was proposed. It had been previously observed in 
other kinetic experiments that the conformational change preceding the cofactor 
dissociation is the overall rate-limiting step in the enzymatic cycle (Grimshaw et al. 
1990; Grimshaw et al. 1995). Different catalytic mechanisms have been proposed during 
the last decades but the most plausible one is based on quantum chemical calculations 
and high resolution structures (Cachau et al. 2002). The protonated Lys77 makes a salt-
bridge with the negatively charged Asp43 and polarizes Tyr48. The singly protonated and 
flexible His110 takes one hydrogen from Tyr48 and then moves toward the substrate and 
donates it one proton. His110 acts as a proton shuttle (Fig. 3.3).  
The first crystal structure of Human Aldose Reductase (Wilson et al. 1992) showed the 
cofactor bound to a cleft running across the C-terminal side of the β/α barrel. The 
cofactor is kept in position by residues which are mostly located in the loop that extends 
from residue Gly213 to residue Leu227 and has been called safety-belt. Inspection of the 
crystal structure of a mutated version of Human Aldose Reductase (Cys298Ser) in 
complex with NADP(H) (Bohrani et al. 1992) and of Porcine Aldose Reductase in 
complex with ADPRP (Rondeau et al. 1992) revealed that the conformation of the safety-
belt strongly depends on the cofactor bound and suggested that a motion of this loop 
between an open and a closed conformation is related to the cofactor up-take and release. 





A mutated version of Human Aldose Reductase (Arg268Ala) could be crystallized 
without the cofactor (Bohren et al. 2005). Indeed the mutation removes an important 
interaction between the cofactor and the enzyme, thereby reducing the affinity of 
NADPH by several orders of magnitude. In this structure of the apo-enzyme the safety-
belt is in a completely open and ordered conformation which is stabilized by a π-stacking 
interaction between Trp219 and Arg293. 
 
3.1.2 High resolution refinement 
Over the last few years developments in X-ray sources, in efficiency of 2D 
detectors and in cryo-freezing techniques have made it possible to obtain macromolecular 
crystal structures at high resolution. The advantages of high resolution and, consequently, 
of a large amount of data are the possibility to solve the structure with direct methods and 
 
 
Figure 3.3 Mechanism of aldehyde reduction by AR (Cachau et al. 2002): Tyr48 acts as first 
proton donor, His110 as proton shuttle, the substrate is reduced to alcohol and the cofactor 
NADPH is oxidized to NADP+. 
 





to appreciate fine details of the structure that can provide additional information useful to 
understand the mechanism of a reaction and the biological role of the molecule (Dauter 
2003). Moreover, it is possible to study the enzyme interactions with ligands like 
inhibitors or substrates, thereby enhancing the development of the drug-design sector.  
High resolution means to have data to a resolution better than 1.2 Å and with 50% of the 
theoretically measurable reflections in the outer shell with an intensity higher than 2 
sigma(I) (Sheldrick 1990). With this resolution it is possible to invert the least-squares 
matrix and to calculate the estimated standard deviations (ESDs) of each individual 
atomic parameter. Normally, ESDs for high resolution structures are much smaller than 
the ones for medium or low resolution structures. This also allows to model the atomic 
displacement parameters (ADPs) anisotropically with the consequent decrease in the 
noise of the maps and the possibility to model flexible parts of the molecule not fully 
occupied. At very high resolution, hydrogens start to be visible in difference maps (Fo-Fc) 
for the well ordered part of the molecule providing the opportunity to observe protonation 
states, to elucidate the catalytic mechanism and to study the network of hydrogen bonds. 
Structures refined at high resolution quite often have lots of disagreeable restraints. The 
restraints used in SHELXL (Sheldrick et al. 1997) are based on the ones of Engh and 
Huber (Engh et al. 1991). They were compiled looking at the structures of amino acids 
and peptides present in the Cambridge Structural Database (Allen 2002). Amino acids in 
proteins are not isolated molecules and can be distorted by the surrounding residues or, 
eventually, by an inhibitor or other molecules present in the crystal. For these reasons, 
structures refined at high resolution show deviations from standard geometry such as non 
planar peptide bond, non planar aromatic ring for aromatic side chains, unusual values of 
chiral volumes and so on. These deviations can indicate special features of the molecule 
that are observable only at high resolution. They may otherwise indicate that the 
restraints used are wrong and the new values found should be used to create a new library 









3.2 Material and methods 
 
3.2.1 Crystallization and data collection 
Human Aldose Reductase was crystallized by the vapour diffusion method. 
The protein concentrated to 16mg/ml in 50 mM Ammonium Citrate buffer (pH 5), was 
mixed with the cofactor NADP+ and the stereoisomer 2R4R of the inhibitor Fidarestat in 
a 1:2:2.5 ratio. The solution containing the protein, the cofactor and the inhibitor was 
mixed with an equal volume of 15% (w/v) PEG6000 in 50 mM Ammonium Citrate 
buffer at pH 5. The reservoir solution (1 mL) contained 120 mM Ammonium Citrate and 
20% (w/v) PEG6000. The hanging drops had a volume of 10 μL. Crystals grew at 4° C 
 
 
Figure 3.4 Graph showing the values of the B factors (in red) and of the scale factors (in blue) for 
each 20th frame of the high resolution pass. The decrease of the scale factors and the increase of 
the B factors could be a sign of radiation damage. 





and, prior to data collection were transferred first into a stabilization solution (25% (w/v) 
PEG 6000) and then into a cryoprotecting solution (40% (w/v) PEG6000). Data to 0.82 Å 
were collected from a single crystal at the beamline ID19 at the APS, Structural Biology 
Centre at 10 K, λ = 0.7999 Å using a marCCD detector (Mar Research, Norderstedt, 
Germany). Two data sets were collected: a low-resolution one extending to 1.44 Å (676 
frames with an oscillation angle of 0.5°) and a high-resolution one extending to 0.82 Å 
(1690 frames with an oscillation angle of 0.2°). In the high-resolution data set, refined 
scale factors decreased from 0.8844 to 0.5458 and B values increased from 0.42 to 0.98 
between frames 900 and 1690. Both these observations might indicate some radiation 
damage (Fig. 3.4). Anyway other sources like incorrect centering of the crystal, 
inaccurate spindle movement or imperfect stability of the beam cannot be excluded. 
Thus, only intensities from the low-resolution data set (cut at 1.8 Å) and the first 900 
frames of the high-resolution data set (cut at 8 Å, corresponding to 180° rotation of the 
crystal) were used to construct the merged data set for refinement. The data were 
integrated and scaled using HKL2000 and SCALEPACK (Otwinowski et al. 1997) while 
further data analysis and merging were performed using the Bruker program XPREP. 5% 
of the reflections were randomly flagged by XPREP for use in cross-validation. The 
crystal belongs to the monoclinic space group P21, with the unit cell parameters a = 
47.44, b = 66.73, c = 49.29 Å, α, = 90, β = 91.55, γ = 90°. Data statistics are shown in 
Table 3.1. 
Resolution range (Å) 34.6 - 0.82 
No. of observations 394966 
No. of unique reflections 131238 
Redundancy 4.26 (3.34) 
<I/σ(I)> 26.11 (12.24) 
Completeness (%) 94.3 (90.3) 
Rint §(%) 4.21 (8.43) 
 
Table 3.1 Data statistics of native Human Aldose Reductase in complex with NADP+. Values 
between parenthesis are for the highest resolution shell (0.92-0.82 Å, corresponding to 96796 
reflections; § ( )∑ ∑−= I/IIR int ). 





3.2.2 Structure determination 
The structure was solved by molecular replacement. Data in the resolution 
range 15-4 Å were used. The atoms belonging to the protein and the cofactor NADP+ of 
the crystal structure of the complex Aldose Reductase-IDD384 (Calderone et al. 2000) 
were chosen as search model. The molecular replacement was carried out with the 
program EPMR (Evolutionary Programming for Molecular Replacement, (Kissinger et 
al. 1999)). In this program an efficient six-dimensional search is implemented using an 
evolutionary optimization algorithm: a starting set of random molecular replacement 
solutions is iteratively optimized against the correlation coefficient between observed and 
calculated structure factors. In the case of human Aldose Reductase the best solution had 
a correlation coefficient of 68.9% and an R factor of 34.3%. The rotation function was 
characterized by Euler angles of θ = 261.51°, φ = 91.77° and ω = 269.68° and the 
translation function by three vectors tx = 23.59 Å, ty = -0.10Å and tz = 9.42 Å. 
 
3.2.3 Refinement 
The refinement was carried out with the program SHELXL (Sheldrick et al. 
1997) using the normal procedure for high resolution structure (Table 3.2). The model 
coordinates found by molecular replacement were first refined with twenty cycles of 
least-squares (LS command) refinement. For this purpose the molecule was considered 
as a single rigid-body and only data to 2.5 Å were used. Least-squares refinement was 
possible at this stage because the amount of parameters was still small. For a better 
convergence, the resolution was increased from 4 Å to 2.5 Å in step of 0.1 Å (STIR 
command). The B factors were initially refined as isotropic using data to 1.5 Å and 
conjugate gradient least-squares refinement (CGLS command). At this point water 
molecules were added automatically with the program SHELXWAT. The initial isotropic 
value U for waters was set to 0.1 Å2, in each cycle up to 50 solvent molecules were added 
and waters with isotropic U value higher than 0.2 Å2 were rejected. In each job waters 
were added in ten cycles and after each cycle a normal SHELXL refinement was 
performed. In total four jobs of SHELXWAT were carried out. The waters were added 





automatically looking at the peaks in the difference electron density map and taking into 
account also chemical information such as the possibility to make hydrogen bonds. The 
model was then refined against all data and the B factors were refined anisotropically 
(ANIS command): Rwork and Rfree drop to 14.5% and to 15.9% (with a difference in Rfree 
equal to 3.9%) respectively. It was only at this stage, that a systematic checking of the 
model with particular attention to disordered side chains and to high peaks visible in 
difference electron density maps was made by visual inspection with the program XFIT 
(McRee 1999). More details are given in the next subchapters. Cycles of iterative 
rebuilding and refinement were carried out until the end of the refinement was reached. 
Finally twenty cycles of conjugate gradient least-squares refinement were carried out 
using all data. The trend of the refinement is shown in Fig. 3.5. Error estimates of all 
parameters (bond lengths and angles, planarity etc) were obtained through inversion of 
the least-squares matrix. Because the amount of parameters was extremely large, the 
block matrix least-squares approximation was used. Simultaneously all the restraints 
were removed and the damp for all parameters was set to zero (BLOC and DAMP 0 0 
commands).  The  refinement  was  considered  to  be  completed  when  no  more  entries 
Step(s) Remark Resol. (Å) # data # param. Rwork (%) Rfree(%) 
1 Rigid body refinement 10-2.5 10008 2582 40.0 39.7 
2 Isotropic B refinement 10-1.5 46050 10295 28.0 31.2 
3-6 Waters added 10-1.2 89112 11243 19.5 21.9 




10-0.82 268333 25293 14.5 15.9 
9-46 Rebuilding 10-0.82 268333 32565 10.7 12.4 
47 Add hydrogens Inf-0.82 268491 32565 9.8 11.1 
48 All data (no Rfree) Inf-0.82 282631 32565 9.8  
 
Table 3.2 Major refinement steps with the corresponding Rwork and Rfree. The column data list the 
unique data including the 5% of them used for the cross-validation (Rfree). 
 





unjustifiable in the list of disagreeable restraints, no peaks higher than 5 sigma in the 
difference map and no decrease of Rwork and Rfree were seen.  
 
3.2.3.1 Refinement of disordered side chains 
At high resolution it becomes possible to model disordered residues in two 
conformations. The disorder can involve only the side chain atoms or also backbone ones 
but the way to proceed to model them is the same in both cases. There are different things 
to look at to detect possible disordered residues: 
- atoms with extremely high B values 
- list of disagreeable DELU/SIMU restraints (longer than 3 sigma) in the .lst file 
- atoms flagged as "may be split" or "non positive definite" 
- peaks higher than 5 sigma in the difference electron density map (Fo-Fc) near an atom. 
Once the candidate disordered residues had been detected, the electron density was 




























Figure 3.5 Trend of Rwork (blue squares) and Rfree (red squares) during the refinement. 
 





already modeled and some positive density in correspondence of the probable second 
conformation (Fig. 3.7A). The occupancy of the main conformation was fixed to 65% 
and some cycles of refinement were carried out. Then the electron density maps were 
again carefully inspected and the second conformation was modeled in the positive 
electron density (Fig. 3.7B). The occupancy was refined using free variables and 
restraining the sum to be equal to one. After refinement of the second conformation 
neither positive nor negative density was visible and the disordered residue was fitting 
nicely in the σA weighted (2mFo-DFc) electron density map (Fig. 3.7C). An example of 




Figure 3.6 Example of part of the instruction file of SHELXL (.ins). FVAR are the free variables. 
In this case the second one is associated with the occupancy of residue 133. The atoms of the main 
conformation (PART 1 21.00) will have an occupancy equal to the refined value of FVAR while 
the ones of the second conformation (PART 2 -21.00) will have one equal to (1-FVAR). 









Figure 3.7 Example of disordered residue modeling (Ser133). σA weighted (2mFo-DFc) map 
contoured at 1σ is colored in blue while positive and negative difference maps (Fo-Fc) contoured at 
2.5σ are colored in green and red respectively. A) The residue is fully occupied in a single 
conformation. B) The occupancy of the atoms CB and SG has been decreased to 65% and the 
second conformation has been modeled. C) The final model with occupancy refined to 59.3% for 
the main conformation (in grey) and to 41.7% for the second conformation (in yellow). 





Part of the disordered residues was already visible in the first stages of the refinement, 
while other regions became clearer only when the phases got better. Some residues 
showed a disorder that could have been modeled in more than just two conformations. 
Attempts to model them in three conformations did not improve the model and it was 
therefore decided to refine them in two conformations only. The main conformation of 
other residues was not fully occupied but it was not possible to model a second one. The 
occupancy of connected disordered residues was refined to the same value using the same 
free variable. 
Particular attention was given to the active site and the safety-belt loop. A molecule of 
the stereoisomer 2R4R of the inhibitor Fidarestat should have been present in the active 
site. When the inhibitor was placed in the active site and refined, even if only partially 
occupied, negative difference electron density (Fo-Fc) appeared. It was then decided to 
put a molecule of citrate instead, but after some cycles of refinement it became clear that 
this molecule too was not fully occupied. The occupancy of the citrate in the major 
conformation was then fixed to 64% and after some cycles of refinement a second 
conformation was modeled in the appearing positive difference electron density map (Fo-
Fc). A similar approach was used to model the second conformation of the safety-belt 
loop: the occupancy of the main conformation was fixed to 64% together with the B 
values and the minor conformation was partially built in the positive difference electron 
density map (Fo-Fc). The occupancy of the citrate in the active site, of the residues of the 
safety-belt loop, of other residues connected to them and of some waters was refined 
using only one free variable (see Appendix B).  
 
3.2.3.2 Refinement of waters  
The first 237 water molecules were added automatically by the program 
SHELXWAT. More waters were then added manually looking at peaks higher than 5 
sigma in the difference electron density map (Fo-Fc). If a peak could make hydrogen 
bonds with the surrounding residues or waters and if it had tetrahedral coordination 
geometry, then it was modeled as the oxygen atom of a water molecule (Fig. 3.8A/B). 






Waters were refined into three major groups: 
-  fully occupied waters  
- partially occupied waters connected to disordered residues or to at least two water  
molecules  
- couples of half occupied waters. 
 
3.2.3.3 Hydrogens 
Hydrogen atoms have only a single electron and consequently their scattering 
power is weak. For this reason, even at high resolution, their signal disappears in the 
noise and hydrogens are visible in positive difference electron density map (Fo-Fc) only 
for the well ordered parts of the molecule. Hydrogens are normally added in calculated 
positions. They are not refined as independent atoms but as "riding" on the atom they are 
attached to (HFIX command). Hydrogens attached to nitrogen atoms of the imidazole 
ring of His, to the oxygen atom of the hydroxyl group of Tyr, Thr and Ser were not 
 
 
Figure 3.8 Example of water modeling. A) Peak higher than 5σ in the difference (Fo-Fc) electron 
density map (shown in green and contoured at 2.5σ) has a round shape σA weighted (2mFo-DFc) 
density map (shown in blue and contoured at 1σ) and makes hydrogen bonds with the surrounding 
residues showing a tetrahedral coordination. B) The peak was refined as the oxygen atom of a 
water molecule with occupancy set to 1. 
 





added: they can occupy several possible positions and if a wrong one is automatically 
chosen, the antibumping restraints could cause problems. 
 
3.2.3.4 Disagreeable restraints 
A careful inspection of the list of the disagreeable restraints was made. The 
major restraints used in SHELXL and interesting for such a study are: antibumping 
restraint, chiral volume restraint and flatness restraint. The antibumping restraints 
(BUMP) are generated automatically after each cycle of refinement and they prevent  the 
distance between two non-bonded atoms from being shorter than a certain value. They 
should avoid unfavorable side chain conformations. The chiral volume restraints (CHIV) 
are used to prevent wrong chirality or disallowed conformations. The flatness restraints 
(FLAT) ensure peptide bonds and some groups (aromatic ring, guanidinium group) to be 
flat. The list of disagreeable restraints written out after the last refinement was checked 
together with the model and with the electron density map after refinement with and 
without restraints in order to see if the restraints were wrong or if the structure was 


























3.3 Results and discussion 
 
3.3.1 Aspects of high resolution refinement 
Some aspects characteristic of high resolution refinement are analyzed in the 
following subchapters. First a careful inspection of disordered residues will be shown 
with particular attention to the presence of clusters; then analysis of waters and 
hydrogens will be carried out followed by an examination of disagreeable restraints. At 
the end the calculation of the estimated standard deviations (ESDs) of the parameters 
used and an overall picture of the quality of the model will be presented. 
 
3.3.1.1 Disordered regions  
The modeling of disordered residues in two conformations generally 
decreases the B values of the atoms involved, the amount of peaks visible in positive 
difference electron density map and both Rwork and Rfree. Due to the absence of the 
inhibitor in the active site, the whole molecule of Aldose Reductase studied here presents 
a high level of disorder with 89 out of 315 (27.8 %) residues modeled in more than one 
conformation. Most of the disordered residues are concentrated in the loops (66 out of 89 
total disordered residues corresponding to 75%). 52 residues are disordered and isolated 
(Fig. 3.9A/B/C). The majority of the disordered residues (40) also have their backbone 
refined in more than one conformation (Fig. 3.9D) while in 29 residues (9 Lys) it is only 
the side chain that is disordered. For 21 residues it was possible to model only one 
conformation but not fully occupied. Part of the second conformation of the safety-belt 
loop (Ala220 to Asp224) and the last three residues at the C-terminal side (Glu313, 
Glu314 and Phe315) were not visible in the electron density map. The residues with 
disordered or not fully occupied side chains are in most of the cases located on the 













Figure 3.9 Example of disordered residues. The main conformation is always drawn in grey while 
the minor one in yellow. σA weighted (2mFo-DFc) density map (contoured at 1σ) is shown in blue. 
A) Residue Thr144 with an occupancy for the main conformation equal to 80.5% and of the 
second one to 19.5%. B) Residue Glu193 with the main conformation refined with an occupancy 
of 72.9% and the second one of 27.1%. C) Residue Lys100 for which also the backbone has been 
modeled in two conformations (occupancy of the main one equal to 60.9% and of the second one 
equal to 39.1%). D) Example of backbone disorder: residues Phe276, Asp277, Phe278 have two 
conformations characterized by a shift of the main chain. 
 





side chains of some Glu residues show a clear negative difference electron density (Fo-
Fc): due to radiation damage (Weik et al. 2000) these residues may have been 
decarboxylated during the data collection. The disorder of some residues had to be 
coupled because they were directly interacting through hydrogen bonds or through waters 
or they were clashing with each other (Fig. 3.10). Four couples of disordered residues 
were indeed modeled using the same free variables. A significant part of the residues 
modeled in multiple conformations were refined in clusters (Table 3.3). One of the 
clusters includes residues of the strand from His83 to Leu87 and of the loop from Ser133 





Figure 3.10 Example of residues refined using the same FVAR. In green the main conformation 
where Ser93 and Gln97 are making a strong hydrogen bond (green dashed line) is shown while the 
second conformation, where a water molecule was also refine, is shown in cyan. 






The main conformation has an occupancy of 58.3% (Fig. 3.11). Another cluster includes 
the safety-belt loop residues (Gly213 to Ser227), the citrate in the active site, the residues 
Lys21, Cys296, Asp256 and nine waters. The main conformation has an occupancy of 
66%. A detailed discussion of the safety-belt loop is presented in section 3.3.2.3. Lys21 
in the main conformation makes the characteristic salt-bridge with Asp216 while this 
does not occur in the second one (Fig. 3.12). The occupancy of the eight residues of the 
loop from Leu124 to Val131 together with two waters was also refined using a single free 









Couple Residues Waters  Occupancy main conformation (%) 
I N40-V67  51.1 
II Q93-S97 4005, 4029 56.5 
III E229-K234 4004, 4028 57.2 
IV I4-K194 4009 62.0 
Cluster Residues Waters Occupancy main conformation (%) 
I H83-L87; S133-L137 A: 4034, 4036, 8001, 8002, 8003, 
8004, 8005 
B: 4035, 8006, 8007, 8008 
58.7 
II K21; D216-D224; N256; 
C298; CIT320 
A:4013, 4018, 4020 
B: 4001, 4006, 4016, 4017, 4019, 
4021 
63.8 
III L124-D125; S127-V131 4014, 4036 69.1 
 
Table 3.3 Residues and waters refined in couples and clusters. In the case of waters A indicates 
the most occupied site and B the second one. 











Figure 3.11 Residues refined in cluster I. The main conformation (occupancy = 58.7%) is shown 
in green and the second one (occupancy = 41.3%) in cyan. Some of the waters refined in this 
cluster are also shown here. 
 
 
Figure 3.12 Salt-bridge (drawn as green dashed line) between Lys21, Lys262 and Asp216 in the 
closed conformation of the safety-belt loop (in green). In the open conformation (shown in cyan) 
only Lys21 is interacting with Asp216 (blue dashed line). 





3.3.1.2 Waters  
The solvent content of human Aldose Reductase crystals is 43%; that means 
that about 2000 molecules of water should be present in the model. The problem of the 
bulk solvent persists also at high resolution and most waters are still disordered and form 
a continuum of electron density. At this resolution is usually possible to see ordered 
waters of the first and second solvatation shell.  
The final model contains a total of 477 water sites (Fig. 3.13), which can be divided into 
three groups:  
- 373 fully occupied sites  
   - 38 pairs of partially occupied sites (Fig. 3.14) 
- 66 partially occupied sites connected to disordered protein atoms or to at least two    
other water molecules. 
Almost all the fully occupied sites were found automatically in the first stages of the 
refinement. Fully occupied water molecules form networks of hydrogen bonds either with 
atoms of the protein side chains or with other waters; consequently they have quite low B 
values (20 Å2). During the refinement, some of the waters showed an ellipsoid shape of 
the electron density and high B values: they were thus refined in two positions with an 
occupancy of 50% each. The occupancy of waters that were clashing with disordered 
residues or that were interacting with them through hydrogen bonds was refined to the 
 
 
Figure 3.13 Water molecules refined in the Aldose reductase structure. 





same value using a single free variable.  
3.3.1.3 Hydrogens 
At high resolution the data-to-parameter ratio allows the addition of 
hydrogens to the model. In the very well ordered regions of the model with low B values 
hydrogens become visible in the positive difference electron density map (Fo-Fc) 
contoured at 2.5 sigma (Fig. 3.15A). In other parts of the molecule hydrogens, which 
have very low scattering power, were not detectable. In both cases they have been 
included in the calculated positions using the "riding" model. After putting the hydrogens 
Rwork and Rfree dropped down by 1.2% and 1.3%, respectively. In the difference electron 
 
 
Figure 3.14 Example of partially occupied sites for two water molecules. The σA weighted (2mFo-
DFc) density map (contoured at 1σ) has an ellipsoid shape. The two sites, each 50% occupied, are 
shown as red and yellow spheres.  
 





density map (Fo-Fc) of the well ordered regions of the protein peaks were no longer 
visible and the noise of the maps generally decreased (Fig. 3.15B). 
Hydrogens of the hydroxyl group of Thy, Ser, Thr, hydrogens attached to the imidazole 
ring of His and hydrogens of the cofactor were not modeled. In the positive difference 
electron density map (Fo-Fc) it could clearly be seen that the catalytic residue His110 is 
singly protonated on NE1 (Fig. 3.16A). The analysis of the difference electron density 
maps also allowed the unequivocal identification of the redox state of the cofactor 











Figure 3.15 A) σA weighted (2mFo-DFc) density map (contoured at 1σ) in blue and difference 
(Fo-Fc) electron density map contoured at +2.5σ (in green): most hydrogens are visible. B) The 
two maps after the refinement with hydrogens placed in "riding" position. 
 





3.3.1.4 Analysis of disagreeable restraints 
Structures refined at high resolution show deviations from standard geometry 
such as non planar peptide bond, non planar aromatic ring for aromatic side chains, 
unusual values of chiral volumes and so on. In the case of Aldose Reductase a total of 
268 disagreeable restraints are listed at the end of the last conjugate gradient least-
squares refinement (see Appendix C).  
41 of them are antibumping (BUMP) restraints. 10 of them involve hydrogens, 3 atoms 
belonging to the cofactor NADP+ and 12 molecules of water. The largest violations 
involve atoms of disordered side chains and carbonyl groups of the backbone. Tyr209 
shows two violations: an excessively short distance between the C carbon atom of the 
carbonyl group and the CD1 of the side chain (3.18 Å instead of 3.3 Å) and an 
excessively short distance between CD1 and C17 of the cofactor (3.19 Å instead of 3.3 
Å). These interactions are due to the bend of the aromatic ring of Tyr209 that is 
 
 
Figure 3.16 In blue is shown the σA weighted (2mFo-DFc) density map contoured at 1σ and in 
green is shown the positive difference (Fo-Fc) electron density map contoured at 2.5σ. A) His110 
is singly protonated on NE1. B) The hydrogen on C18 shows that the cofactor is oxidized 
(NADP+) and in a post-reaction state. 
 





interacting with the cofactor nicotinamide ring via a π-stacking interaction. The bend of 
the aromatic ring was visible in the electron difference map too (Fig. 3.17A/B). Also the 
oxygen atom of Ala299 is too near the carbon atom C of Leu300 (2.69 Å instead of 2.8 
Å). In this region the molecule is distorted because of a strong hydrogen bond between 
the oxygen of Ala299 and the hydroxyl group of Tyr309 (O...H 2.60 Å). 
There are 21 disagreeable restraints of the distance between two atoms (DFIX) and 85 of 
the angle distance (1-3 distance, DANG). Of these 12 involve the cofactor or the citrate 
molecules, 10 safety-belt loop residues and all of them involve disordered residues.  
Almost all the 18 violations on the restraints of chiral volume (CHIV) involve the 
didahedral angle formed by N, C, CA and CD of Pro. The residues are anyway well 
ordered with low B values and they fit nicely in the electron density map. 
The list of the 24 disagreeable flat (FLAT) restraints is more interesting. 13 of them 
involve peptide bonds. In recent years, with an increasing number of high resolution 
structures coming out, it has been noticed that generally peptide bonds are not perfectly 
planar (Wilson et al. 1998). In the structure of Aldose Reductase ω angles show a broad 
distribution centered around 179.23° (Fig. 3.18). The ω angle between residues 132 and 
133a shows an extreme value of 159.95°. This region is disordered and in both 
conformations Ser133 is making strong hydrogen bonds with surrounding residues like 
 
 
Figure 3.17 Residue Tyr209 is drawn as ball-and-stick, σA weighted (2mFo-DFc, contoured at 1σ) 
electron density map is shown in blue and difference (Fo-Fc, contoured at 2.5σ) electron density 
maps are shown in green (positive one) and red (negative one). A) After refinement using the 
FLAT restraint. B) After refinement with the FLAT restraint taken out: the ring is clearly not 
planar but bent. 





Glu84 (2.71 Å) and Thr135 (2.94 Å). Even all the other disagreeable flat restraints 
involving peptide bonds are due to strong hydrogen bonds (the shortest being the one 
between the oxygen atom of Val297 and NE1 of Trp219 equal to 2.62 Å, see also 
subchapters 3.3.2.2. and 3.3.2.3). Flatness disagreeable restraints are also found for the 
plane of aromatic rings of some side chains (one Phe, three Trp and five Tyr residues). 
The violation of the flat restraint for the Tyr209 aromatic ring, which interacts with the 
cofactor nicotinamide ring via a π-stacking interaction is particularly big (1.73 equal to 
17.2 sigma). 
The restraints of anisotropic parameters (DELU and SIMU) are quite well fulfilled and 
the violations generally involve disordered or not fully occupied sites.  
 
3.3.1.5 Quality of the model 
The agreement of the model with the data is excellent as shown by the low 
crystallography R values of Rwork = 9.8% and Rfree = 11.2% (for Fo > 4σ(Fo)). Out of the 




Figure 3.18 Histogram showing the distribution of the ω angle around the mean value of  179.23°. 
 





Reductase contains 315 residues, the cofactor NADP+, two citrate molecules, and 555 
water sites. The protein is described by 1968 fully occupied and 1033 partially occupied 
sites, while in the solvent region 383 fully and 142 partially occupied sites were modeled. 
The cofactor is fully ordered. One of the citrate molecules is fully occupied and located 
on the surface of the protein close to Gln49, Glu53, Asp98, Lys94; the other one is 
present in two conformations in the active site. 
All dihedral angles of the protein backbone fall in the allowed (88.9%) and additionally 
allowed (10.4%) regions of the Ramachandran plot (Fig. 3.19) (Ramachandran et al. 
1963) as defined in the program PROCHECK (Laskowski et al. 1993). 
The mean B values for the fully and partially occupied sites of the protein are 7.5 ± 3.7 
Å2 and 12.1 ± 3.7 Å2, respectively. The fully occupied waters have a mean B value of 
20.3 ± 3.7 Å2 and the partially occupied ones of 15.7 ± 3.7 Å2. The average anisotropy 
(the ratio of the minimum to the maximum eigenvalue of the Uij tensor, E11/E33 (Merritt 
 
 
Figure 3.19 Ramachandran plot for human Aldose Reductase. Almost all residues are nicely 
packed in the most favored regions. 





1999)) is about 0.45, a normal value for high resolution structures (Fig. 3.20). 
The coordinate uncertainties for fully and partially occupied sites of the protein are 0.011 
Å and 0.059 Å respectively. The cofactor, which is fully occupied and in a rigid 
conformation, has very low ESD (0.007 Å) while the disordered citrate molecules have 
higher ESD (0.046 Å). The fully occupied water molecules have estimated coordinate 











Figure 3.20 Structure of anisotropically refined human Aldose Reductase. Atoms with low B 
values are coloured in blue while the ones with high B values are shown in red.  
 





Resolution range (Å) Inf - 0.82 
No. of reflections 282631 
Rfree / Rwork [Fo > 4σ (Fo)] (%) 11.11 / 9.82 
Rfree / Rwork (all data) (%) 11.34 / 10.04 
No. of reflections [Fo > 4σ (Fo)] 265969 
R1 for Fo > 4σ (Fo) (%) 9.84 
R1 for all data (%) 10.06 
No. of parameters 32562 
No. of refined non-H sites  
Total (full / partial) 2087 / 1222 
Protein (full / partial) 1968 / 1033 
Cofactor (full / partial) 48 / 0 
Water (full / partial) 383/ 142 
Citrate (full / partial) 0 / 39 
R.m.s. deviations from ideal values  
Bond distances (Å) 0.017 
Angle distances (Å) 0.045 
Planar groups (Å) 0.417 
DELU (Å2) 0.006 
SIMU (Å2) 0.034 
ISOR (Å2) 0.082 
Average isotropic B factors  
Protein (full / partial) (Å2) 7.5 / 12.1 
Cofactor (full / partial) (Å2) 5.6 / - 
Water (full / partial) (Å2) 20.3 / 15.7 
Citrate (full / partial) (Å2) - / 12.4 
Average coordinate uncertainties  
Protein (full / partial) (Å) 0.011 / 0.059 
Cofactor (full / partial) (Å) 0.007 / - 
Water (full / partial) (Å) 0.031 / 0.041 
Citrate (full / partial) (Å) - / 0.046 
 
Table 3.4 Statistics for the refinement of human Aldose Reductase ( ∑ ∑−= oc0 F/FF1R ). 






3.3.2.1 Overall structure 
The overall structure of human Aldose Reductase is the same as in the 
previously determined structures of the molecule (Fig. 3.21). It folds as an eight-stranded 
β/α barrel with a small β-sheet on the N-terminal (residues 2-14) and a C-terminal 
extension (residues 275-315). The active site is located at the end of the barrel and the 
NADP+-binding site is near the hydrophobic active site pocket. The cofactor is bound to 
the protein and the active site contains one citrate molecule and several molecules of 
water. The most interesting features of the structure are the safety-belt loop modeled in a 
close conformation and a partially open one, and the presence of a disordered citrate 






Figure 3.21 Overall structure of human Aldose Reductase. The safety-belt loop (residues 213-
226) and Cys298 are shown in green; for Asp216, Trp219 and Cys298 the side chains are 
depicted. The loop opposing the safety-belt loop (containing residue Lys21 that makes a crucial 
salt-bridge to Asp216 in the closed conformation of the safety-belt loop) is shown in blue. The 
cofactor and the ligand are shown in orange and yellow, respectively. Side chains of Tyr48 and 
His110 are shown as yellow sticks. 





3.3.2.2 Active site 
Although the crystals used in this study were obtained by cocrystallization of 
the protein with the cofactor and the stereoisomer 2R4R of the inhibitor Fidarestat (El-
Kabbani et al. 2004a), it was not possible to model the difference electron density present 
in the active site by placing fully or partially occupied copies of the inhibitor molecule. 
After careful inspection, it was decided to model the density as two overlapping partial 
conformations of citrate (which was present in the crystallization buffer) leading to a 




Figure 3.22 Crossed-eyes stereo views of electron density for citrate bound in the active site. A) 
σA weighted (2mFo-DFc) electron density map (contoured at 1σ) and the main conformation of the 
citrate (occupancy = 64%). B) Difference (Fo-Fc) electron density map (contoured at 2.5σ) as 
calculated in the presence of the citrate main conformation but before adding the minor conformer 
(occupancy = 36%). The refined position of the second conformation is shown. 





As in many other determined structures (Bohrani et al. 1992; Wilson et al. 1992; Wilson 
et al. 1993; Bohren et al. 1994; Harrison et al. 1994; Harrison et al. 1997; Calderone et 
al. 2000; Kinoshita et al. 2002; El-Kabbani et al. 2003; El-Kabbani et al. 2004a; El-
Kabbani et al. 2004c; Howard et al. 2004; Ruiz et al. 2004), the catalytic residues Tyr48 
and His110 interact with a carboxylate group of the ligand, in this case a molecule of 
citrate. In both conformations the citrate molecule is indeed anchored to the active site 
via hydrogen bonds to Tyr48 and His110 (Table 3.5 and Fig. 3.23A/B). Except for this 
strong interaction the second conformation is interacting only weakly with Cys298 via a 
normal hydrogen bond and with Trp20 via a π-hydrogen bond.  
Instead the main conformation interacts with residues situated in different parts of the 
active site, connecting them to each other. The same carbolxylic group that interacts with 
Tyr48 and His110 is making a π-hydrogen bond with the cofactor nicotinamide ring and a 
normal hydrogen bond with the nitrogen atom NE1 of Trp111. The carboxylic group on 
the other side of the citrate molecule is acting as a bridge between Trp20 and Trp219 of 
the closed conformation of the safety-belt loop. The O6 atom is located in the plane of 
the Trp219 imidazole at a distance of 4.41 Å from the center of mass of the six-
membered ring of imidizole, indicating an interaction between O6 and the edge of the 
aromatic system (Meyer et al. 2003). The geometry of this interaction is in good 
agreement both with the results of quantum mechanical calculations for the interaction 
between oxygen and the edge of benzene (Thomas, 1982) and with statistical analyses of 
Citrate conformation A Citrate conformation B 
atom citrate atom distance (Å) atom citrate atom distance (Å) 
O3 C18_318 3.29 O1 O_5039b 3.22 
 OH_48 3.14 O2 O_4033b 2.89 
 NE2_110 2.81 O3 C18_318 3.32 
O4 C18_318 4.14 O4 C18_318 3.13 
 OH_48 2.71  NE2_110 2.72 
 NE2_110 3.34 O5 O_3143 2.30 
 NE1_111 2.99  O_4017b 2.74 
O5 NE1_20 2.95  O_4021b 3.33 
O6 CH2_219a 3.21  O_4033b 3.22 
   O6 SG_298 3.22 
 
Table 3.5 Interactions of the two conformations of the citrate molecule in the active site with 
surrounding residues and water molecules. 





protein structures (Hakansson 1996). 
 
3.3.2.3 The safety-belt loop 
Correlated with the two conformations of citrate in the active site, the safety-
belt loop is also present in two conformations. For the major conformation, the entire 
polypeptide chain between Gly213 and Ser226 could be placed into electron density, 
although for residues Asp216 to Asp224, the atomic sites are only partially occupied. The 
structure of the major conformation (occupancy = 64%) of the safety-belt corresponds to 
the closed conformation present in most of the structures of the holo-enzyme and it is 
characterized by hydrogen bonds between the carboxylate of Asp216 and the amino-
groups of Lys21 and Lys262 (Wilson et al. 1992) with lengths of 2.95Å and 2.82Å, 
respectively. For the minor conformation (occupancy = 36%), only residues Asp216 to 
Trp219 are visible in the electron density (Fig. 3.24). This intermediate open 
conformation is stabilized by interactions between Pro218 and Trp219 with Asn256 of a 
symmetry-related molecule: Pro218 makes a hydrogen bond via its carbonyl oxygen to 
 
 
Figure 3.23 Interactions of the citrate (shown in yellow) in the active site. Residues belonging to 
the protein are drawn in grey (safety-belt loop in green), the nicotinamide ring of the cofactor in 
orange. A) Main conformation. B) Second conformation. 
 





the amide nitrogen while the imidazole of Trp219 makes a π-stacking interaction with the 
guanidinium group of Asn256 (Fig. 3.25).  
In terms of opening of the safety-belt the minor conformation seen here corresponds to an 
intermediate conformation between the closed and the open conformation as observed in 
the mutant Arg268Ala of Aldose Reductase by Bohren et al. (2005) as residues Gly213 
to Pro215 remain in the closed conformation and the region between Ala220 and Ser226 
is disordered (Fig. 3.26)(Bohren et al. 2005). The necessary but not sufficient condition  
 
 
Figure 3.24 The σA weighted (2mFo-DFc, contoured at 1σ) map and the difference map (Fo-Fc , 
contoured at 2σ) as calculated in the presence of the safety-belt loop main conformation (drawn in 
grey) but before adding the minor conformer, are drawn in blue and green respectively. The 
refined position of the second conformation of the safety-belt loop is shown in yellow. 
 






for the opening of the safety-belt loop is the possibility for the sulphur atom of Cys298 to 
interact with the positive charged nicotinamide ring of NADP+. It is known (Duan et al. 
2001) that Cys can interact with aromatic rings or through π–hydrogen bonds or through  
electrostatic potential attraction between the negative charged lone pairs of the sulphur 
atom and the positive electrostatic potential of the aromatic ring. In all but one of the 
structures solved until now the safety-belt loop is in the closed conformation. In some 
structures the inhibitor binds in the specificity pocket (residues Thr113, Phe115, Phe122, 
Cys303, Tyr309) making the whole molecule and consequently the loop 213-226 more 
rigid (PDB-ID: 1pwl (El-Kabbani et al. 2004b), 1us0 (Howard et al. 2004), 1t40, 1t41 
(Ruiz et al. 2004)). When the inhibitor interacts strongly with Leu300 (PDB-ID: 1iei 
(Kinoshita et al. 2002) and 1pwm (El-Kabbani et al. 2004b)) the whole molecule 
becomes more rigid. In other two structures Cys298 (PDB-ID: 1iei and 1pwl) strongly 
interacts with the inhibitor thereby excluding a possible interaction with the nicotinamide 
 
 
Figure 3.25 Interaction between the open conformation of the safety-belt loop in grey (Pro218) 
and a symmetry related molecule in yellow (Ans256). 
 





ring of the cofactor NADP+. If Trp219 (PDB-ID: 2acq (Harrison et al. 1994), 2acu 
(Bohren et al. 1994) and 1el3 (Calderone et al. 2000)) or Pro218 (1el3) are making strong  
interactions with the inhibitor, the safety-belt loop cannot be in the open conformation. 
For other structures the open conformation could be possible: for some of them the 
electron density map for that region (checked using the Uppsala Electron Density Server, 
http://fsrv1.bmc.uu.se/eds, (Kleywegt et al. 2004)) is not clear (PDB-ID: 1az1 (Harrison 
et al. 1997)). For others, for which no structure factors are deposited, the B values of the 
residues 213-226 are extremely high (PDB-ID: 1ads, 2acs and 2acr (Harrison et al. 
1994)). In the structure of the apo Arg268Ala Human Aldose Reductase (PDB-ID: 1xgd, 
 
Figure 3.26 Safety-belt loop in different conformations. The closed and open conformation of the 
present model are shown in red and yellow, while the open conformation found in the structure of 
the R268A mutant apo-AR is shown in green. The side-chain of Trp219 is drawn as sticks and the 
cofactor is depicted in blue. 
 





(Bohren et al. 2005)) the safety-belt loop is in the open conformation. In this case the 
affinity of the enzyme for the cofactor is decreased by a point mutation of residue Arg268 
to Ala. The cofactor is not present in the crystal structure and Cys298 can be involved in 
an aromatic sulphur interaction with Trp22. The open conformation, where the safety-belt 
loop is displaced by 17 Å at most, is stabilized through an aromatic π-stacking interaction 
between the aromatic ring of Trp219 and the guanidinium group of Arg293. The 
movement of the safety-belt seems not to be a rigid one but probably the exposed loop is 












2acq 8.74 8.36 10.43 8.29 
2acr 8.66 8.50 9.98 8.25 
2acs 8.73 8.51 7.12 9.32 
2acu 8.67 8.42 10.11 7.85 
1ads 8.83 8.58 8.51 6.93 
1az1 8.67 8.31 9.05 9.04 
1az2 8.41 7.90 9.79 9.75 
1ef3 (chainA) 8.80 8.60 10.00 8.02 
1el3 8.73 8.48 9.34 9.42 
1iei 9.08 8.18 8.56 7.02 
1mar 8.75 8.53 9.83 8.49 
1pwl (chainA) 8.67 8.74 9.82 8.34 
1pwm (chainA) 8.77 8.40 10.10 8.47 
1t40 8.70 8.50 9.63 9.17 
1t41 8.70 8.57 9.78 8.43 
1us0 8.67 8.35 9.92 8.58 
1x96 8.77 8.48 10.03 8.19 
1x97 8.78 8.51 9.95 8.30 
1x98 8.76 8.52 10.11 8.48 
1xdg 8.88 9.00 9.89 8.17 
cit. (conf.A) 8.77 8.54 10.16 8.44 
 
Table 3.6 Distances between Cα atoms of residues of the safety-belt loop. The distances are 
different in the different structures showing that the movement of the loop is probably not rigid. 





3.3.2.4 The tongs movement 
The structure of Aldose Reductase presented here was compared with other 
four high resolution structures of Aldose Reductase (PDB-ID: 1pwm, 1pwl, 1us0, 1t41). 
A qualitative comparison was carried out by visual inspection of the models in PYMOL 
(DeLano 2002). Since studies on the different binding modes of inhibitors and on the so-
called induced-fit phenomena have already been made (Klebe et al. 2004; Podjarny et al. 
2004; Sotriffer et al. 2004), the aim of this comparison was to detect the possible 
presence of domains movements. 
The overall structures of 1pwl, 1pwm and 1t41 are very similar to each other while they 
differ from the ones of 1us0 and the one described in this paper (abbreviated as cit). The 
rigid β–sandwich (domain S3, S4, S5, S6, S7, S8, S9 according to the topology diagram 
of AR (Harrison et al. 1994), Fig. 3.27) is the same in all five structures as well as the 
strand S2, part of the helixes H3 and H4, the loop between H4 and S7, the helixes H7, H8 
and the loop connecting the two.  
In the structure 1pwl the loop 112-137 (between S6 and H4) and the loop 214-231 
(between S9 and H7) are much closer to each other than in 1us0 and cit (Table 3.7). 
 
 
Figure 3.27 Topology diagram of Aldose Reductase. The β/α barrel is shown in dark and light 
blue, the safety-belt loop between S9 and H7 and two extra helices are shown in green, and the 
two short β strands at the N-terminal side in yellow. 





On the opposite side of the molecule, the helix 280-289 (H10) and the region 164-175 
(loop after S7 and part of H5) are farther away from each other in 1pwl than in 1us0. In 
the present model this part does not move so much (see Fig. 3.28). It can be asserted that 
a domain movement has been detected, where the upper part is closing, the central one is 
motionless and the lower part is opening. This domain movement as been called “tongs 
movement". The loops involved in this movement are quite flexible, far from the active 
site and they show high B values. Therefore this movement is probably not related with 
the size or the chemical structure of the inhibitor. The inhibitors Minarelstat in 1pwl and 
IDD594 in 1us0 are indeed similar: both interact with the specificity pocket via a 
distance (A-B) Å Δdistance(A-B) Å res. A res. B 
1pwl (closed) 1us0 (medium) Cit (open) 1pwl-1us0 cit -1us0 
D224 N129 24.19 25.27 26.03 -1.08 0.76 
E223 G128 24.56 26.11 26.81 -1.55 0.8 
P122 S127 26.42 28.17 29.61 -1.75 1.44 
K221 E126 25.12 26.8 28.12 -1.68 1.32 
W219 G128 15.64 17.16 18.13 -1.52 0.97 
average Δdist(A-B)    -1.52 1.06 
  1pwl (open) 1us0 (closed) cit (med.) 1pwl-1us0 cit-1us0 
K172 S282 39.01 37.34 37.45 1.67 0.11 
 Q283 41.06 39.6 39.7 1.46 0.1 
P173 S282 41.38 40.53 40.69 0.85 0.16 
 Q283 43.62 42.9 43.04 0.72 0.14 
G174 S282 42.52 41.12 41.3 1.4 0.18 
 N283 44.87 43.72 43.88 1.15 0.16 
L175 S282 39.13 37.71 37.89 1.42 0.18 
 N283 41.48 40.34 40.1 1.14 0.24 
average Δdist(A-B)    1.23 0.16 
  1pwl 1us0 cit 1pwl-1us0 cit-1us0 
G18 D43 5.01 5.03 5.02 -0.02 -0.01 
L17 D43 5.89 5.93 5.94 -0.04 0.01 
G16 I42 5.27 5.21 5.25 0.06 0.04 
L15 H41 6.76 6.79 6.79 -0.03 0 
D43 V75 4.98 4.96 4.96 0.02 0 
I42 I74 5.21 5.22 5.21 -0.01 -0.01 
H41 F73 4.52 4.54 4.54 -0.02 0 
average Δdist(A-B)    0.02 0.01 
 
Table 3.7 Distances between residues of the regions of the molecule involved in the "tongs" 
movement. 
 





Bromine and a Fluorine atom on the benzyl ring and both make interactions with the 
anion binding site, the first one through the cycled imide ring and the second through the 
carboxylic head. It could also be that the loops show different positions because of their 
intrinsic flexible nature or the movement could be just a crystal packing artefact. 
Inspection of the models did not show any strong interactions between the loops and 









Figure 3.28 Superposition of 1us0 (in cyan), 1pwl (in red) and cit (in green) that shows the loops 
involved in the "tongs" movement. 





3.4 Conclusions and perspectives 
In this chapter the structure of human Aldose Reductase in complex with citrate to a 
resolution of 0.82 Å has been described. The atomic resolution data allowed to model 
more multiple conformations than in the previously determined structure (88 vs. 47) and 
to improve the fit between model and the data (Rfree 11.2% vs. 20.1%).  
Particular attention was paid to the inspection of the list of disagreeable restraints. Some 
of them (chiral volume of nitrogen atom of Pro) are probably due to wrong restraints 
while others (flatness of the peptide bond or of the ring of some aromatic residues) are 
real features of the structures observable only at high resolution and probably caused by 
strong interactions. These observations should be used to build a new library of restraints, 
to explain in more details the structure and to better interpret the role of the molecule. 
The most interesting feature of this model is the safety-belt loop modeled in two discrete 
conformations. The common closed conformation with an occupancy of 64% is stabilized 
by the main conformation of the citrate molecule in the active site that connects Trp219 
to residues of the active site, some of which (Tyr48 and His110) are known to be very 
rigidly placed. The partially open conformation was possible because the holo-enzyme is 
in a post-reaction state. Indeed, from the hydrogen atoms present on the nicotinamide 
moiety of the cofactor the reduced state of it was confirmed. In the minor conformation, 
the citrate molecule does not make an interaction with Trp219. This conformation of the 
citrate is correlated with a ‘half-open’ conformation of the safety-belt loop, indicating 
that the removal of one interaction is enough to trigger the release of the cofactor. Such a 
transition, from a situation where the safety-belt is kept closed due to interactions with 
substrate or product of the catalytic reaction to a situation where the safety-belt can open 
because important interactions can not be kept after release of the product, could well be 
the structural basis for the regulation of cofactor release.  
Careful inspection of different high resolution structures reveals a domain movement that 
has been called "tongs movement": loops at the top and at the bottom are closer to or 
farther away from each other, while the β-barrel stays rigid. This movement could be 
related to the post reaction state of the molecules and to the release of the cofactor.  





In the context of drug-design, the present study shows that Trp219 in the safety-belt in its 
closed conformation provides an interaction point for ligands. This interaction could be 
exploited in the construction of AR inhibitors to achieve an increase of both affinity and 
specificity.





4 C2A domain of Rabphilin3A 
  
4.1 Introduction 
In this chapter the crystal structure of the C2A domain of Rabphilin3A to a resolution 
of 1.92 Å is presented (PDB-ID: 2ch0, (Biadene et al. 2006)). Rabphilin3A is a neuronal 
protein implicated in the synaptic vesicle cycle and its exact biological role still remains 
to be elucidated. The structure presents new features with respect to other C2 domains 
suggesting a new function for this domain. 
 
4.1.1 The synaptic vesicle cycle 
Signal transduction processes can be carried out under hormonal control or 
via synaptic transmission of nervous impulses. Inside a single neuron the impulse is 















Figure 4.1 Scheme of the synaptic vesicle (green circles) trafficking. Red arrows show exocytosis 
steps while yellow arrows show the different possibilities for the endocytosis process. The small 
red circles represent neurotransmitters molecules (NT). 





of the membrane. When the impulse has to go through different neurons, it has to cross 
the synaptic junction. Neurotransmitter release is then mediated by exocytosis and 
endocytosis of synaptic vesicles at the presynaptic active zone of the nerve terminal. 
Exocytosis is triggered by Ca2+: Ca2+ ions enter through Ca2+ channels and bind to Ca2+ 
sensors inducing fusion-pore opening. The endocytosis follows three different possible 
routes: the vesicles can be refilled without undocking, they can undock and then be 
recycled locally or they can be refilled through a clathrin intermediate (Fig. 4.1, for 
review (Sudhof 2004)). Synaptic vesicles contain two major classes of proteins: the ones 
involved in neurotransmitter up-take (called transport proteins) and the ones that 
participate in exo-, endocytosis and recycling (named trafficking proteins) (Fig. 4.2). 
Transport proteins form a large multiprotein complex that works as a proton pump that, 
generating an electrochemical gradient, up-takes neurotransmitter molecules (for review 
(Fykse et al. 1996)). Trafficking proteins can be intrinsic membrane proteins, proteins 
associated via posttranslational lipid modification and peripherally bound proteins.  
The four different classes of soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor (SNARE) proteins  characterized by the so called SNARE motif (70 
residues) take part in intracellular membrane fusion (for review (Chen et al. 2001; Jahn et 
al. 2003)). The function of SNARE proteins is regulated by a class of essential fusion 
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Figure 4.2 Schematic representation of a synaptic vesicle that shows the most important 
trafficking proteins. The C2 domains are shown in orange and the intermembrane regions in 
yellow. For simplicity Rabphilin has been associated only to the protein Rab3A, B and C. 





proteins called Sec1/Munc18-like (SM) proteins (Jahn et al. 2003) and by 
Synaptophysins (Johnston et al. 1990; Calakos et al. 1994; Edelmann et al. 1995; 
Washbourne et al. 1995). Synaptotagmin I and II are involved in endocytosis and 
synaptic fusion: they can bind up to five Ca2+ ions through two C2 domains (Ubach et al. 
1998; Fernandez et al. 2001), interact with SNARE complexes (Bennett et al. 1992; 
Chapman et al. 1995; Li et al. 1995a; Shin et al. 2003) and form calcium/phospholipid 
complexes. Rab3 (Schluter et al. 2002), Rab5 (von Mollard et al. 1994) and Rab11 
(Khvotchev et al. 2003) are regulators of synaptic vesicles fusion and they can bind to the 
effectors Rabphilin (Shirataki et al. 1993; Li et al. 1994) and RIM1α/2α (Wang et al. 
1997; Wang et al. 2000; Wang et al. 2003) that are located in the active zone and that in 
turn interact directly or indirectly with many other synaptic proteins. The function of 
Synaptic vesicle proteins 2a (SV2s) (Buckley et al. 1985) is not yet fully understood but 
they may regulate Ca2+ levels (Janz et al. 1999). Finally Synapsins (see Fig. 4.2) are 
probably required to maintain the right number of synaptic vesicles and to regulate short-
term synaptic plasticity (Rosahl et al. 1993; Li et al. 1995b; Rosahl et al. 1995). 
 
4.1.2 Rabphilin3A 
Rabphilin3A is a peripheral membrane protein found on synaptic vesicles. It 
is expressed in neurons and neuroendocrine cells. It has a relative molecular mass of 78 
kDa and comprises 710 residues (Shirataki et al. 1993). The N-terminal region (residues 
40-170) contains two α-helical regions and a cysteine rich zinc-finger domain that can 
interact with Rab3A-GTPase (Stahl et al. 1994; McKiernan et al. 1996; Chung et al. 
1997), Rab27 (Fukuda 2003), Rabaptin5 (Ohya et al. 1998) and α-actinin (Kato et al. 
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Figure 4.3 Schematic representation of the domain organization of Rabphilin3A. 





1996; Baldini et al. 2005). Next a long linker region of about 120 residues, the C-terminal 
part (residues 396-704) contains two C2 domains (homologous to the ones of 
Synaptotagmin) which can bind phospholipids in a Ca2+-dependent manner (Yamaguchi 
et al. 1993; McKiernan et al. 1996; Chung et al. 1998; Ubach et al. 1999) and β-adducin 
(Miyazaki et al. 1994) (Fig. 4.3). The function of Rabphilin3A is not yet fully 
understood. Studies carried out in recent years showed that Rabphilin3A was involved in 
neurotransmitter release with a subsection of reactions and that it could eventually be 
considered a positive regulator of exocytsosis (Chung et al. 1995; Burns et al. 1998). An 
additional role in endocytosis through interaction of the N-terminal region with 
Rabaptin5 was proposed by Ohya (Burns et al. 1998; Ohya et al. 1998). On the opposite, 
later studies based on genetic mutations considered Rabphilin3A as a non-specific Rab3 
effector (Schluter et al. 1999; Staunton et al. 2001). Rabphilin3A needs Rab3 for stability 
and synaptic location but the viceversa does not apply. At the same time Rab3A can also 
work perfectly in the absence of Rabphilin3A. Moreover the role of Rabphilin3A as a 
major synaptic Ca2+ sensor in exocytosis was excluded. It was instead proposed that the 
function of the C2 domains is probably independent from the binding to Rab3A and that 
Rabphilin3A has not a fundamental but a specialized role under extreme physiological 
conditions (Schluter et al. 1999). Fukuda (Fukuda 2003) proposed Rabphilin3A as an 
effector of Rab8A, Rab27A and Rab3A. Other studies claimed that Rabphilin3A could be 
involved in the docking step of regulated exocytosis through a direct interaction between 
the C2B domain and the plasma membrane protein Synaptosome-associated protein of 25 
kDa (SNAP25), a target SNARE (Tsuboi et al. 2005). A function of Rabphilin3A as a 
linker for Rab3A and different cytoskeletal proteins has been proposed. Rabphilin3A 
interacts through the C2 domain with β-adducin (Miyazaki et al. 1994). The protein α-
actinin instead interacts with the N-terminal region and this interaction stimulates the 
activity of α-actinin to cross-link actin filaments into a bundle (Kato et al. 1996; Baldini 
et al. 2005). In the light of all these observations the exact biological role of Rabphilin3A 
still remains to be elucidated. 
 
 





4.1.3 C2 domains 
C2 domains are intracellular protein modules about 130 residues long with a 
structure characterized by a pair of four-stranded β-sheets that form an eight-stranded 
antiparallel β-sandwich. They adopt alternative type I (if located more towards the C-
terminus) and type II (if located more towards the N-terminal region) connectivities that 
differ by circular permutation of their topology (Fig. 4.4, for review (Nalefski et al. 1996; 
Rizo et al. 1998)). The loops between strand β2 and β3 (called CBL1) and the one 
between β6 and β7 (called CBL3) form a bidentate Ca2+ binding site (Sutton et al. 1995; 
Essen et al. 1996). Two to three Ca2+ ions can be coordinated with low intrinsic affinity 
(Shao et al. 1996; Ubach et al. 1998; Fernandez et al. 2001) but the binding does not 
induce large conformational changes (Shao et al. 1998). C2 domains are widely 
distributed in eukaryotes and the proteins in which they are found can be divided into 
four classes: Ca2+-sensory vesicular transport proteins (Synaptotagmin, Rabphilin, 
Double C2-like domain-containing proteins), lipid-modifying enzymes (Cytoplasmic 
phospholipase A2, Phosphoinositide-specific phospholipase C, Plant phospholipase D), 
protein kinases regulated by Ca2+ or phospholipids (Protein kinase C, Protein kinase C-
 
             
 
Figure 4.4 The two different topologies found in C2 domains. A) Topology I (found also in 
Rabphilin3A). B) Topology II. 





like kinase, Serine/Threonine-protein kinase SCH9) and GTPase activating proteins (Ras-
GTPase-activating protein, Ras-GTPase-activating protein 1). C2 domains seem to have 
diverse functions. They can bind Ca2+ and can interact with cellular membranes and 
mediate both protein-protein interactions and small molecule binding. In the structure of 
the complex of Protein Kinase Cα (PKCα) with phosphatidyl serine the Ca2+ ions act as a 
bridge between the ligand and the membrane (Verdaguer et al. 1999). A two steps 
mechanism has been proposed in which the first Ca2+ ion triggers the interaction with the 
negatively charged phosphatidyl serine while the other calcium binding region (CBL3) 
penetrates into the phospholipid bilayer.  
C2 domains can act as a Ca2+-dependent electrostatic switch (Shao et al. 1997). The 
interaction between Synaptotagmin I and Syntaxin via CBL3 is mediated by Ca2+ 
binding. In the absence of Ca2+ the calcium binding site formed by five negatively 
charged Asp residues is surrounded by four basic residues and the electrostatic potential 
of the region is zwitterionic. The electrostatic surface of this region becomes positive 
upon Ca2+ binding and consequently the interactions with the Asp rich syntaxin become 
stronger.  
Rabphilin3A has two C2 domains in its C-terminal region: C2A that includes residue 396 
to residue 530 and C2B that includes residue 548 to residue 669. The structure of the 
C2B domain has been elucidated both by NMR (Ubach et al. 1999) and X-ray 
crystallography (Schlicker et al., personal communication). The C2 domain tandem, 
characteristic also for the synaptotagmin protein family, shows a functional cooperativity 
and it is essential for the function of these proteins (Bai et al. 2004). Elucidating the 













4.2 Materials and methods 
 
4.2.1 Crystallization and data collection 
For crystallization the protein was concentrated in 10 mM HEPES, pH 7.0, 
150 mM NaCl, 1 mM DTT to a final concentration of 10 mg/mL. The reservoir solution 
contained 25% PEG 4000 (w/v), 0.1 M Ammonium Sulphate and 0.1 M Sodium Acetate, 
pH 4.6. Drops were set up in 96 well Greiner low profile plates using a Mosquito robot 
(TTP Labtech). 100 nL of the protein solution were mixed with 100 nL of the reservoir 
solution. Crystals (Fig. 4.5) appeared overnight and grew for about two weeks. Trials to 
scale up these conditions in 24-well plates with the hanging-drop method were not 
successful. 
Crystals were soaked in a cryosolution containing 30% (v/v) of glycerol, mounted in 
Hampton loops and flash-cooled in a stream of liquid nitrogen. Data were collected in-
house in fine-sliced mode (0.2º) using a Bruker rotating-anode generator, CuKα radiation, 
Osmic focusing mirrors and a Bruker SMART6000 4K CCD detector placed at a distance 
of 7 cm. The exposure time was 70 seconds for the low-resolution pass and 120 seconds 
for the high-resolution data collection. The best crystal was diffracting to 1.82 Å. The 
data were indexed with the Bruker program PROTEUM, integrated with the Bruker 
program SAINT and scaled with the Bruker program SADABS. After scaling, the statistics 
 
 
Figure 4.5 Crystal of C2A domain of Rabphilin3A of dimension 0.25 x 0.03 x 0.05 mm3. 
 





and the space group determination were performed with the Bruker program XPREP. In 
the light of the statistics the data were cut at 1.92 Å. The crystals belong to the 
orthorhombic space group P212121, with the unit cell parameters a = 37.84, b = 39.16, c = 
88.95 Å, α, β, γ = 90°. There is one molecule per asymmetric unit and the solvent content 
of the crystals is 39.8%, with a Matthews coeffcient of 2.1 Å3Da-1. The data statistics are 
shown in Table 4.1. 
 
4.2.2 Structure determination and refinement 
The structure has been determined by molecular replacement using data in 
the range 35.8-2.5 Å. The search model was based on the structure of the C2A domain of 
Synaptotagmin I (PDB-ID: 1rsy, residues 140-265, (Sutton et al. 1995)) which has a 
sequence identity of 40% (Fig.4.6). The  final  search  model was  generated  by replacing  
the residues that were different with Ala. Using this mixed model a solution has been 
found with the program PHASER (McCoy et al. 2005) of the CCP4 package 
(Collaborative Computational Project 1994). In PHASER a two steps molecular 
replacement search is made using likelihood method: first a rotation function search is 
performed, followed by a translation function search. The best solution had a log-
likelihood gain of 10.52 and a Z score of 10.20. The rotation function was characterized 
Resolution range (Å) 44.41-1.92
No. of observations 65418 
No. of unique reflections 10435 
Redundancy 6.13 (2.74) 
<I>/σ(I) 19.11 (3.09) 
Completeness (%) 97.8 (92.6) 
Rint§ (%) 5.15 (28.37) 
 
Table 4.1 Data statistics for the C2A domain of Rabphilin3A. Values between parentheses are for 
the highest resolution shell (1.95–1.92 Å, corresponding to 439 observations; § 
( )∑ ∑−= I/IIR int ). 
 





by three Euler angles θ = 24.3°, φ = 127.7° and ω = 138.4° and the translational function 
by three vectors tx = -0.419, ty = -0.25 and tz = -0.073. After twenty cycles of rigid-body 
refinement in REFMAC (Rwork = 53%, Rfree = 54%) (Murshudov et al. 1997) the program 
RESOLVE was employed for density modification and for model building (Terwilliger 
2002). Density modification was performed with the prime-and-switch procedure of 
RESOLVE to reduce model bias. RESOLVE uses maximum-likelihood density 
modification based on three quantities: the prior knowledge of the structure factors, the 
likelihood of the observed set of structure  factors and the likelihood of  the map resulting 
from them (Terwilliger 2000). In the prime-and-switch procedure phases of an atomic 
model are used to calculate an initial electron density map. The probability function for 
the map is computed and phases are adjusted to maximize this probability function 
(Terwilliger 2004). The partial model obtained from RESOLVE contained 111 correctly 
 
 
Figure 4.6  Sequence alignment for several C2 domains (performed with the program Vector 
NTI). Red boxes highlight identical residues, orange boxes conserved ones. The blue box shows 
the DED motif present in Rabphilin, DOC2A/B and Munc13-1/2/3 proteins. The secondary 
structure elements were drawn according to the structure of the C2A domain of Rabphilin3A. The 
blue arrows represent the β-sheet and the green box the α-helix. The Ca2+ binding residues 
conserved in the structure of Synaptotagmin I and C2A domain of Rabphilin3A are represented by 
the dark blue asterisks while the only non-conserved one by the light blue asterisk. 
 





placed residues (104 of them with side chains built) out of 127 (Rwork = 36%, Rfree = 
38%). Further tracing and rebuilding was carried out using the graphics program COOT 
(Emsley et al. 2004) alternating with refinement in REFMAC. 
After a few refinement cycles 84 waters have been automatically added with ARP/wARP 
(Lamzin et al. 2001) in REFMAC with a drop in Rwork and Rfree of 3.2% and 1.9%, 
respectively. ARP/wARP adds waters in place of peaks higher than 0.5 sigma. If two 
peaks are closer than 2.2 Å they are merged together. New waters are added if closer than 
3.3 Å and farther than 2.2 Å to each other. The B values were initially refined 
isotropically while at the end TLS refinement (Winn et al. 2001) was carried out 
considering the whole protein as a single domain. The final model from the REFMAC 
refinement has an Rwork = 19.6% and Rfree = 26.0 %, contains 127 residues, 66 water 
molecules and one glycerol molecule. The model of the last REFMAC refinement was 
further refined using SHELXL (Sheldrick et al. 1997). The version of SHELXL used was a 
test version with restraints that mimic a TLS refinement (see Chapter 5 for more details). 























new SHELXL  
 
Figure 4.7 Graphic that shows the trend of Rwork (in blue) and Rfree (in red) during the major steps 
of the refinement. 





4.3 Results and discussion 
 
4.3.1 Quality of the model 
As described in the previous section the model of the C2A domain of 
Rabphilin3A was refined in REFMAC using TLS minimization considering the whole 
molecule as a single domain. The results of the TLS refinement have been analyzed with 
the program TLSANL (Howlin et al. 1993). The analysis of the TLS refinement shows 
that the main libration is along the z axis (Fig. 4.8). No atoms are non positive definite. 
After refinement with REFMAC, the gap between Rwork (19.6%) and Rfree (26.0%) was 
relatively large (6.4%). On the contrary the refinement with SHELXL resulted in a 
considerably smaller gap between the two values (4.7%) and in a lower Rfree (24.0%) 
suggesting that the restraints applied are more suitable at this resolution (for more 
detailed discussion see Chapter 5). 
 
Figure 4.8 Model of the C2A domain after TLS refinement in REFMAC and analysis with 
TLSANL. Atoms with high anisotropy are drawn in red.  





Analysis with PROCHECK (Laskowski et al. 1993) shows that the overall geometry of 
the structure is quite good: 83.5% of the residues are in the most favorite regions, 14.8% 
in the additional allowed ones and 1.7% in the disallowed region of the Ramachandran 
plot (Fig. 4.9).  
The only two residues in the disallowed region are Ser431 and Lys432 for which the 
electron density is not well defined, in line with a relatively high B value (45 Å2). The 




Figure 4.9 Ramachandran plot for the final model of the C2A domain of Rabphilin3A. Ser431 and 
Lys432, for which the electron density is not clear are in disordered region. 
 





The average B value of the 1056 protein atoms in the asymmetric unit calculated with 
Baverage in the CCP4 package is 27.7 Å2. The root mean standard deviation (r.m.s.d.) for 
the bond lengths is 0.005 Å while the r.m.s.d. for the angle distances (distance 1-3) is 
0.023 Å.  
 
4.3.2 Structure description 
The refined crystal structure of the C2A domain of Rabphilin3A includes 
127 residues (residue Tyr382 to residue Val509) (Fig. 4.10), 66 water molecules and one 
glycerol molecule. The structure consists of a compact β-sandwich formed by two four-
stranded β-sheets, one small helix (residues 460-465) and three loops (loop1: residues 
407-419, loop 2: residues 441-447 and loop3: residues 476-479) at the top and the bottom 
of the sandwich, respectively. The C2A domain has the topology I found in all other C2 
domains of synaptotagmin proteins (Fig. 4.11). 
It was also attempted to obtain the structure of Rabphilin3A with Ca2+ ions bound but, 
after soaking the crystals in solution containing different concentrations of Ca2+ their 
diffraction quality dramatically decreased. Also trials to cocrystallize Rapbhilin3A with 
Ca2+ did not succeed.  
Rwork (%) 19.3 
Rfree (%) 24.0 
No. of protein atoms per asymmetric unit 1056 
No. of non-protein atoms 72 
r.m.s.d bond lengths (Å) 0.005 
r.m.s.d. angle distance (Å) 0.023 
Average B (Å2) 27.7 
Ramachandran plot statistic  
Residues in most favored regions (%) 83.5 
Residues in additional allowed regions (%) 14.8 
Residues in disallowed regions (%) 1.7 
 
Table 4.2 Data statistics for the final model of the C2A domain of Rabphilin3A refined with 
SHELXL. 
 






Although Ca2+ ions have not been found in the structure, the loops located in the Ca2+ 
binding region (residues 411-421, called CBL1 and 474-484, called CBL3) are well 
ordered: for CBL1 the Cα atoms have an average B factor of 19 Å2, while for CBL3 the 
average B factor is 23 Å2 (Fig. 4.12). 
 
 
Figure 4.10 Overall structure of the C2A domain of Rabphilin3A. The two calcium binding loops 
are denoted as CBL1 and CBL3.  
 
Figure 4.11 Topology diagram of type I of C2A domain of Rabphilin3A. 









Figure 4.12 σA weighted (2mFo-DFc) electron density map (contoured at 1σ) of the regions CBL1 
and CBL3 and some of the residues normally involved in Ca2+ binding (Asp413, Asp419, Glu475, 
Asn481) are shown. Even if no Ca2+ ions are present the loops are well ordered. Water molecules 





Figure 4.13 σA weighted (2mFc-DFo) electron density map (contoured at 1σ) of residue Cys401. 
The two conformations of the sulfur atom (each with occupancy = 50%) are shown in yellow and 
orange. 





The residues conserved among different C2 domains and involved in Ca2+ binding (Asp 
413, Asp419, Asp474, Asp476 and Glu482) are in the Ca2+-free conformation with the 
side chains in an orientation similar to the one described in the Synaptotagmin I C2A 
domain crystal structure (Sutton et al. 1995).  
The electron density was generally of good quality except for the N-terminal part of the 
fourth β-strand where it was not possible to build the side chains of some residues while 
the main chain could be unambiguously traced. Double conformations of the side chain 
were modeled for 6 out of the 127 residues (Cys401, His425, Asp434, Lys439, Asn450, 
Arg469; Fig. 4.13). For four residues (Gln460, Glu461, Lys492, Lys495) located on the 
surface of the protein only part of the side chain has been modeled. A cis-peptide bond 
was detected between Leu427 and Pro428 in the same position as in other C2 domains 
structures (Pro202 in the PKCα (Verdaguer et al. 1999) and PKCβ (Sutton et al. 1998), 
Pro411 in the C2A domain of Synaptotagmin III (Sutton et al. 1999) and Pro187 in the 
C2A domain of Synaptoptagmin I (Sutton et al. 1995)). 
One glycerol molecule, presumably introduced by soaking with glycerol for 
cryoprotection, has been modeled near Asn481, Lys423 and Lys410 of a symmetry-
 
 
Figure 4.14 The glycerol molecule found in the structure and the residues that interact with it 
(Lys423 and Arg437) are shown in the σA weighted (2mFo-DFc) electron density map (contoured 
at 1σ).  





related C2A molecule (Fig. 4.14). The glycerol molecule is in the same position as a 
phosphate found in the structure of Synaptotagmin III (Sutton et al. 1999) and it might 
mimic the negative head of a phospholipid molecule. As Sodium Sulphate was a 
component of the crystallization condition, it was also tried to place a sulphate ion 
instead of glycerol into this electron density, but this resulted in very high B values, 
suggesting that glycerol was the better choice. 
 
4.3.3 Comparison with other C2 domains 
The crystal structure of the C2A domain of Rabphilin3A has been compared 
with the structures of the C2A domains of Synaptotagmin I (PDB-ID: 1rsy, (Sutton et al. 
1995)), Synaptotagmin III (PDB-ID: 1dqv, (Sutton et al. 1999)) and the C2 domains of 
PKCα (PDB-ID: 1dsy, (Verdaguer et al. 1999)) and of PKCβ (PDB-ID: 1a25, (Sutton et 
al. 1998)). A superposition of the structures was carried out using the program SSM 
(Krissinel et al. 2004) within COOT (Emsley et al. 2004). All five structures are similar 
to each other with differences concentrated in the loops. The root mean square deviations 
between the structure described here and the C2A domains of Synaptotagmin I and 
Synaptotagmin III are 1.21 Å and 1.81 Å, respectively and the ones with the C2 domains 
of PKCα and PKCβ are 1.44 Å and 1.45 Å, respectively. In all the cases the differences 
are quite small.  
The major differences between the structure of the C2A domain of Rabphilin3A and of 
the C2A domain of Synaptotagmin I, which was used as a search model in the molecular 
replacement, are visible in calcium binding loops 1 (CBL1) and 3 (CBL3) that connect 
strands β2 and β3 and strands β6 and β7, respectively (Fig. 4.15). CBL1 of Rabphilin3A 
is flipped by 20° and rotated by 90° against CBL1 of the homologous C2 domains of 
Synaptotagmin I, III and PKCα and PKCβ, but in all the structures it is well ordered (B 
values of 15-20 Å2). A consequence of these structural changes is a significant shift of the 
position of residue Asp413 compared to the equivalent residue Asp172 of the C2A 
domain of Synaptotagmin I. The longer side chain of Glu482, as compared to the oxylic  







Figure 4.15 Superposition of C2 domains. The C2A domain of Rabphilin3A is shown in cyan, the 
one of Synaptotagmin I in green, the C2 domain of PKCα is drawn in magenta and the one of 
PKCβ in grey. 
 
 
Figure 4.16 : σA weighted (2mFo-DFc) electron density map (contoured at 1σ) of the loop between 
residues 411-421 and the strand from residue 482 to 484. The density for some side chains has 
been omitted for clarity. The hydrogen bond between Asp413 and Glu482 is indicated by a dashed 
line. 





moiety and the backbone NH of conserved Asp found in other C2 domains (Asp238 in 
the case of Synaptotagmin I), facilitates a hydrogen bond  between its  carboxylic moiety 
and the backbone NH of Asp413 located in CBL1 (Fig.4.16). Part of CBL3 (residues 
476-481) of the C2A domain of Rabphiln3A is flipped by 56° and rotated by 95° against 
CBL3 of the homologous C2 domains of Synaptotagmin I, Synaptotagmin III, PKCα and 
PKCβ. The loop between the strands β7 and β8 of Rabphilin3A (residues 494-501) is 
similar to the ones of Synaptotagmin I, PKCα and PKCβ. But in the structure of the C2A 
domain of Synaptotagmin III this loop partially folds as a short helix (residues 406-409 of 
Synaptotagmin III) and the backbone of the following six residues (in which are included 
also two inserted residues Pro412 and Asp413, see Fig. 4.6) is tilted in completely 
different direction in comparison to Rabphilin3A, Synaptotagmin I, PKCα and PKCβ 
(Fig. 4.17).  
Among the Ca2+ binding residues commonly found in type I C2 domains, the only 
residue which is not conserved in the C2A domain of Rabphilin3A is Gly479, structurally 
homologous to Ser235 located in CBL3 of the C2A domain of Synaptotagmin I. In the 
structure of Rabphilin3A C2A domain the residues normally involved in the Ca2+ binding 
are in the non-bound conformation. Their side chains are orientated in a different way in 
 
 
Figure 4.17 Superposition of the C2A domain of Rabphilin3A (in cyan) and of Synaptotagmin III 
(in green) that shows the different path of the loop between β7 and β8. The two residues present in 
Synaptotagmin III and absent in Rabphilin3A are shown as sticks. 





comparison to the ones observed in the structure of Synaptotagmin I with Ca2+ bound 
(PDB-ID: 1byn, Fig. 4.18).  
The quality of the electron density of the loop between β3 and β4 is limited in all 
structures discussed so far: in the structure of Synaptotagmin III it is disordered with very 
high B values (90-100 Å2), in the one of Synaptotagmin I four of the residues have zero 
occupancy (Lys189, Lys190, Lys191, Lys192), in the structure of PKCα residues 205 to 
209 have relatively high B values (30 Å2) and in the structure of the C2A domain of 
Rabphilin3A the loop is disordered.  
 
4.3.4 DED motif 
In a recent study the Ca2+ sensitivity of Double C2-like domain-containing 
proteins (DOC2A and DOC2B), two soluble proteins containing C2 domains, has been 
analyzed. It was found that these two proteins, highly related to the synaptotagmin 
 
 
Figure 4.18 Superposition of residues normally involved in Ca2+ binding. Residues of the C2A 
domain of Rabphilin3A are painted in cyan while the ones of the C2A domain of Synaptotagmin I 
and the Ca2+ ions present in that structure are shown in green. 
 





protein family and to Rabphilin, have a high Ca2+-dependent phospholipid binding 
affinity. Therefore it has been hypothesized that this feature could be linked to a DED 
motif found in CBL3 (the two Asp residues are part of the five conserved residues 
involved in Ca2+ binding (Groffen et al. 2006)). In the case of topology type I C2 
domains this motif has been found in C2 domains of DOC2A and DOC2B, MUNC13 and 
Rabphilin3A. In other C2 domains the Glu positioned between the two highly conserved 
Asp residues that are normally involved in the Ca2+ binding, is usually a Tyr or a Phe. 
The three negatively charged residues (DED) probably contribute to the high Ca2+-
dependent phospholipid binding affinity of DOC2A and DOC2B while some minor 
differences in the surrounding residues could simply stabilize the extra negative charge or 
interact with the negative head of phospholipids at the plasma membrane. The structure 
presented here is the first C2 domain structure containing this DED motif. The side chain 
of Glu275 points towards the concave side of the structure, opposite to the Ca2+ binding 
region. It interacts with the conserved residue Glu419 (the distance between the nitrogen 
atom of Glu475 and the carboxyl oxygen atom of Asp419 is 2.98 Å) while the side chain 
is close to the hydroxyl group of Thr440 (distance between OE1 of Glu475 and OG1 of 
Thr440 is 3.31Å) and the guanidinium group of Arg437 (distance between OE1 of 
Glu745 and NH2 of Arg437 is 3.29Å). The electrostatic potential of the C2A domain of 
Rabphilin3A, calculated with the Boltzmam normal equation using the program DelPHI 
(Honig et al. 1995) and mapped onto the molecular surface, shows that the three acidic 
residues of the DED motif form a negatively charged patch together with Asp419 and 
Thr440 (Fig. 4.19). The potential role of this atypical acidic patch might be to be 
involved in a new Ca2+ binding site or to modify the ability of CBL3 to bind Ca2+. 
Further investigations will be necessary to describe the exact role of this specific motif.  
 





4.3.5 Comparison of electrostatic surfaces 
The electrostatic potential of the C2A domain of Rabphilin3A shows a 
positively charged belt surrounded by two localized negative patches (Fig. 4.20). The 
first negative patch is located in the calcium binding region. It contains all the acidic 
residues needed for chelating Ca2+ ions described in Synaptotagmin I C2A and PKCα C2 
domains. The acidic character is then reversed upon binding of Ca2+ ions. This 
electrostatic switch is strictly required to approach the anionic phospholipid subdomains 
(Murray et al. 2002). Previous studies showed that the C2A domain of Rabphilin3A is 
able to interact with phospholipids in a Ca2+-dependent manner suggesting that these 





Figure 4.19 Influence of the DED motif on the electrostatic potential surface close to the calcium 
binding region. A) Ribbon representation of the calcium binding region of the C2A domain of 
Rabphilin3A. The residues Glu482, Asp413, Asp476 and Asp419 are the conserved residues 
involved in the Ca2+ binding (in this view Asp474 lies behind the β-strand 6). The residue Glu475 
from the DED motif forms hydrogen bonds with the Thr440 side chain and the Asp419 backbone 
oxygen. B) The Poisson-Boltzmann electrostatic potential was calculated and mapped onto the 
same view of the C2A domain as shown in A. The close proximity of the residues Glu475, Thr440 
and Glu419, creates a new negative patch next to the calcium binding region.  






The second negative patch sits at the tip located at the opposite end of the domain relative 
to the Ca2+ binding region (CBR) and it involves the acidic residues located in the short 
helix connecting the strands β5 and β6 (residues 460-465), and in the turn between the 
strands β1 and β2 (residues 394-396). This region might be involved in the interaction of 
the C2A domain with a yet unidentified partner. 
The C2A domain of Rabphilin3A forms part of a C2 domain tandem. The electrostatic 
surfaces of both the C2A and the C2B domains show a strongly positive character 
contrary to the Synaptotagmin I C2 domain tandem where the C2A domain is negatively 
charged and the C2B domain is highly basic. This observation suggests different roles for 






Figure 4.20 Electrostatic potential of the surface of C2A domain of Rabphilin3A calculated as in 
Fig. 4.19. The left view shows the concave site of the C2A domain, the Ca2+ binding region is on 
the top; the right view shows the other side of the β-sandwich. The arrow points to the PIP2 
binding polybasic region. 





The residues of the polybasic region of the β-strand 4 of the C2 domain of PKCα that 
have been reported to be responsible for the binding of phosphatidylinositol-4,5-
bisphosphate (PIP2) (Lys197, Lys209, Lys211, (Corbalan-Garcia et al. 2003)), are 
conserved in the C2A domain of Rabphilin3A (Lys423, Lys435, Arg437, see Fig. 4.6). It 
has been shown that the C2A domain of the structure presented here is able to bind 
specifically PIP2 in presence of Ca2+ (Chung et al. 1998). In the structure of the C2A 
domain of Rabphilin3A these conserved amino acids form part of the large basic belt (see 
Fig. 4.20), while in PKCα they were involved in a restricted positive patch. In addition to 
the PIP2 binding, it has been shown that this polybasic region of PKCα is involved in the 
proper subcellular localization of the whole protein upon Ca2+ signaling. It will be 
interesting to study whether this feature might be essential for the role of the Rabphilin3A 
























4.4 Conclusion and perspectives 
The crystal structure of the Ca2+-free form of the C2A domain of Rabphilin3A has 
been determined at 1.92 Å resolution. It has a type I topology and the structure is 
characterized by an eight-stranded antiparallel β-sandwich also found in the C2 domains 
of all synaptotagmins and several protein kinases. The C2A domain of Rabphilin3A has 
Ca2+-dependent membrane binding properties and consequently contains all the acidic 
residues involved in Ca2+ binding. Its electrostatic surface is highly basic and similar to 
the one of the C2B domain of Rabphilin3A. The Ca2+ binding to C2 domains does not 
induce large conformational changes and consequently the Ca2+ binding properties of a 
specific C2 domain cannot readily be inferred from its primary sequence (Dai et al. 
2004). Thus, small structural modifications may be responsible for differences in 
functional specificities from one C2 domain to another. In the C2A domain of 
Rabphilin3A two specific structural features related to deviations from the consensus 
sequence have been found: a different position of the calcium binding loop 1 (CBL1) that 
causes a significant shift of the conserved Ca2+ binding residue Asp413, and the presence 
of the residue Glu475 that creates a localized negative patch close to the calcium binding 
region. Further investigations are needed to determine the relationship between these 











In this chapter tests of a new version of SHELXL (Sheldrick et al. 1997) are 
presented. In macromolecular crystallography one of the biggest problems to overcome is 
the relatively small amount of data in comparison with the parameters refined (low data-
to-parameter ratio, Table 5.1). Two major strategies have been used to get over this 
problem: decrease the amount of parameters introducing constraints into the model or 
artificially increase the amount of data using additional restraints. Known parameters are 
fixed to target values and constraints can be seen as exact mathematical conditions 
applied for example to rigid groups of a molecule or to riding hydrogen atoms. Restraints 
are instead used when the parameters are allowed to deviate from the target values. 
Restraints can then be seen as additional observational equations involving the target 
values T and their standard deviations σ and this term is added to the quantity that has to 
be minimized during the refinement: 
( ) ( )∑ ∑ −+−= 2calcetargtr22calc2obsx TTwFFwM   5.1 
 
where wx are the X-ray weights that should increase as the agreement between observed 
and calculated structure factors improves and wr is equal to 1/σ2.  
Both restraints and constraints are based on previous chemical knowledge from small 








# data per 
parameter 
3.0 2 x y z 0.6 
2.5 4 x y z (B) 1 
2.0 8 x y z B 2 
1.5 20 x y  z B 5 
1.1 50 x y z U11 U22 U33 U12 U13 U23 5 
0.9 90 x y z U11 U22 U33 U12 U13 U23 10 
 






protein structures and normally involve bond lengths, bond angles, planarity or dihedral 
angles. Restraints are also applied to the atomic displacement parameters (ADPs) so that 
the motion described has physical sense. In the next subchapters an introduction of the 
different ways to describe the thermal motion will be presented together with the results 
of a new version of SHELXL. 
 
5.1.1 Atomic displacement parameters 
Atoms of a molecule are fully described by their mean average position and 
by the atomic displacement parameters. ADPs express the mean-square deviation from 
the average position within the normal Gaussian approximation (Willis et al. 1975; 
Trueblood et al. 1996): 
228B μπ=   5.2 
where 2μ  is the mean square displacement. 
The thermal motion of the atoms has different origins. Internal statistic disorder is caused 
by differences in equivalent atomic coordinates between different unit cells while internal 
dynamic disorder is due to the fact that the motion of the atoms is much faster than the 
time of an X-ray experiment. Moreover lattice defects of the crystals and errors in the 
model have to be taken into account. 
Depending on the resolution and consequently on the amount of data, this thermal motion 
can be described in different ways. At very low resolution the B factors are fixed to an 
arbitrary value and not refined. At low resolution an isotropic B factor is associated with 
each atom: the motion of the atom is described by a sphere centered at the average 
position. One parameter (the radius of the sphere) in addition to the position coordinates 
is necessary to fully describe each atom. On the opposite side when high resolution data 
are available and the data-to-parameter ratio is high enough, the thermal motion of each 
atom can be described by an ellipsoid centered at the mean position. Six parameters 






described by nine parameters (Fig. 5.1). At medium resolution, when the amount of data 
is enough to describe the model better than as simply isotropic but not enough for an 
anisotropic description of all the individual atoms, a compromise is to use TLS 
(translation, libration and screw motion) refinement.  
 
5.1.2 TLS 
The total atomic displacement parameter of a crystal can be considered as 
the sum of four separate contributions (Winn et al. 2001): 
atomernalintTLScrys UUUUU +++=   5.3 
where Ucrys is the anisotropy of the crystal and it has to obey the symmetry of the crystal 
space group, UTLS is the TLS motion of pseudo-rigid bodies in the asymmetric unit, 
Uinternal is the collective torsional libration or internal normal modes and Uatom is the 
displacement of individual atoms. The TLS description is based on the assumption of the 
presence of pseudo-rigid bodies in the molecule where a rigid-body is defined as a part of 
the molecule in which all intramolecular links (non-bonded intramolecular distances) are 
 
 








rigid and in which all the atoms move in phase (Didisheim et al. 1987). The theory of 
TLS (Schomaker et al. 1968; Howlin et al. 1989; Schomaker et al. 1998) assumes that 
the instantaneous displacement u  at a point  r  in a rigid-body can be specified as a screw 
motion, that is a rotation of magnitude λ  (in radians)  about a suitably positioned and 
oriented axis λ , correlated with a translation t  parallel to that axis, all vectors being 
specified relative to some arbitrarily positioned and orientated fixed Cartesian axes (Fig. 
5.2): 
rxtu λ+≅    5.4 
where "x" denotes the vector product. The equation is more conveniently written in 
matrix notation: 
rDtu ⋅+=   5.5 
where D  is the rotation matrix and t  the translation vector.  
The dyad product is then: 
TTTTTTT rxxrtxrrxtttuu λλ−−λ+=   5.6 






Figure 5.2 Original description of TLS (Schomaker et al. 1968). The instantaneous rotation 
displacement of an atom originally at r  relative to an arbitrary molecule-fixed origin is given by: 






TTTT rxLxrxSrrxSTuuU −−+=≡    5.7 
where T, L and S are three tensors. The tensor T is symmetric, dependent on the origin 
chosen and it describes the translation. The tensor L is also symmetric but independent 
from the origin chosen and it describes the libration (rotational oscillation). The tensor S 
is asymmetric, dependent on the origin chosen and it describes the average quadratic 
correlation of translation and libration. The trace of S cannot be determined from 
diffraction data alone and it is normally constrained to the arbitrary value of zero.  
Normally the origin is chosen so that T is minimized and S becomes symmetric. There 
are then 20 parameters to be determined for each rigid-body group: 3 rotation amplitudes, 
3 translation amplitudes, 3 screw correlations (out of which only 2 are determined), 9 
angles that describe the orientation of the principal-axes system and 3 coordinates of the 
origin. In the program REFMAC (Murshudov et al. 1997) TLS constraints are combined 
with isotropic refinement of the B factors while in a test version of SHELXL restraints to 
be applied to the ADPs have been modified as to mimic TLS refinement. 
 
5.1.3 New restraints in SHELXL 
In SHELXL normally three restraints are applied to the atomic displacement 
parameters: SIMU, ISOR and DELU (Fig. 5.3). 
The similar ADP restraint (SIMU) takes into account the fact that two spatially closed 
atoms tend to move in the same way (in phase) and consequently the ellipsoids describing 
their motion have to be similar to each other. Six restraints are applied to each pair of 
atoms.  
The isotropic restraint (ISOR) is normally applied to solvent molecules (which are not 
bonded to any other atoms). For these molecules the atomic displacement parameters 
should be approximately isotropic. This restraint is also useful to prevent getting 







With the rigid-body restraint (DELU) the components of the anisotropic motion of two 
atoms along the line joining them are restrained to be equal (Rollett 1970; Hirshfeld 
1976; Trueblood et al. 1983). One strict rigid-bond restraint is applied to each couple of 
atoms and low estimated standard deviations (ESDs) should be used (Didisheim et al. 
1987). 
In a test version of SHELXL a new DELU restraint is implemented. First of all the 
restraint is not applied only to bonded atoms but to atom pairs within a distance of about 
8 Å. In this way not only the component along a bond but the components in any 
directions are restrained. Secondly the differences between the ADP components and Ueq 
of the atoms along the ideal line joining them are restrained to be equal. The ADP 
component along this line and Ueq are both linear combinations of the Uij and 
consequently also the new DELU restraint is a linear restraint. If very small estimated 
standard deviations are used for atom pairs within one domain the DELU restraint can be 
seen as the TLS constraint implemented in REFMAC. Because the ESDs are multiplied 
by the distance between the atoms so that the closer interactions get higher weights, it is 











5.2 Materials and methods 
The new version of SHELXL was tested using different data sets from various 
macromolecules with a typical resolution between 1.2 and 2.3 Å. At this resolution a 
simple isotropic refinement is not satisfactory while a fully anisotropic refinement, due to 
the still low data-to-parameter ratio is not possible. The best way to describe the thermal 
motion of the atoms is then TLS refinement or something similar. For some data sets a 
comparison was made between TLS refinement in REFMAC and the new version of 
SHELXL while for other data sets the comparison was carried out between two versions 
of SHELXL (Table 5.2). 
In the SHELXL instruction file (Fig. 5.4) the new DELU command looks like: 
DELU [k] [d] atomnames 
where: 
− k is the effective standard deviation for which the default value is set to 0.01 Å 
− d is the maximum distance between the atoms to which the restraint is applied. The 
default value is equal to 8 Å. 
 
macromol. name data set name #residues resolution (Å) 
Wind W-His 450 2.35 
Wind Y53F mutant Y53F 449 2.28 
Wind Y55K mutant Y55K 347 2.25 
Aldose Reductase AR 315 2.00 
Concavalin Con20 237 2.00 
C2A domain Rabphilin3A C2A 127 1.92 
Concavalin Con17 237 1.75 
Viscotoxin-a3 Visc-a3 92 1.75 
Wind Y53S mutant Y53S 227 1.75 
Thermolysin Therm 316 1.65 
Glucosoisomerase with Calcium Gi_ca 385 1.60 
Thaumatin Thau 206 1.55 
C2B domain of Rabphilin3A C2B 153 1.28 
Phosphatase tPphA 240 1.19 
 
Table 5.2 Data sets used for testing the new version of SHELXL. The common names, their 






atomnames are the atoms to which the restraint is applied, normally all the atoms of the 
protein. 
For each structure a final refined isotropic model was taken together with a data file (mtz 
or hkl format but with the same reflections flagged for cross-validation in Rfree). The 
structures were then refined with REFMAC with the TLS and restrained refinement 
option on and with the new version of SHELXL using the default setting for the restraints. 
The results of TLS refinement in REFMAC and new SHELXL were compared looking at 
the values of Rwork, Rfree and the gap between them. Some of the structures were refined 
using the two versions of SHELXL. In that case the results were compared looking also at 













5.3 Results and discussion 
 
5.3.1 Comparison between TLS in REFMAC and new SHELXL 
Eight data sets were used to make a comparison between TLS refinement as 
implemented in REFMAC and the new DELU restraint in SHELXL. At low resolution 
(worse than 2 Å; data sets W-His, Y53K, Y55K) REFMAC seems to work better. Both 
Rwork and Rfree are generally lower by about 2% and also the gap between Rfree and Rwork 
is smaller by about 2%. At medium resolution (between 1.65 and 2.0 Å; data sets C2A, 
Y53S and Thermo) the results obtained with the two programs are more or less the same. 
At higher resolution (better than 1.6 Å; data sets Gi_ca and Thau) SHELXL seems to be a 
































R  free REFMAC
R  work RFEMAC
R  new free SHELXL
R  new work SHELXL  
 
Figure 5.5 Graph that shows the results (Rwork and Rfree) obtained using TLS refinement in 







From these results it is evident that REFMAC is working better at low resolution while 
the new version of SHELXL is a good choice at medium resolution. REFMAC is probably 
using a better solvent model and non-crystallographic symmetry is handled better when 
present. The big advantage of SHELXL versus REFMAC is certainly the fact that no 
domains have to be defined. 
 
5.3.2 Comparison between old and new SHELXL 
Fourteen data sets were used to compare the old DELU restraint in SHELXL 
with the new one. Except for two data sets at high resolution (better than 1.3 Å; data sets 
C2B and tPphA), for which a complete anisotropic refinement is justified, in all the other 
cases but one the results of the new version of SHELXL are better than the ones obtained 
with the old version (Table 5.4, Fig. 5.6). The Rfree are generally lower but more 
importantly the differences between Rfree and Rwork became smaller. 
 
 
Data set job Rwork(%) Rfree(%) Rfree-Rwork(%) 
Refmac  22.60 29.34 7.94 W-His Shelxl  24.28 33.38 9.10 
Refmac  21.19 28.06 6.87 Y53F Shelxl  22.09 28.06 5.97 
Refmac  22.63 29.26 6.63 Y55K Shelxl  24.01 32.06 8.03 
Refmac  19.64 26.39 6.75 C2A Shelxl  19.36 24.10 4.74 
Refmac  21.93 26.75 4.12 Y53S Shelxl  21.57 27.17 5.60 
Refmac  15.37 19.09 3.72 Thermo Shelxl  16.70 21.47 4.77 
Refmac  15.79 19.60 3.81 Gi_ca Shelxl  13.42 17.12 3.70 
Refmac  18.84 21.98 3.14 Thau Shelxl  14.14 19.49 5.35 
 









At low and medium resolution (up to 1.75 Å; data sets Y55K, AR, Con20, C2A, Con17, 
Visc-a3,  Y53S)  this gap  is reduced  on average by  about 4%. At higher resolution (data 
sets Thermo, Gi_ca, Thau, C2B, tPphA) an anisotropic refinement for individual atoms 
start to be plausible and the difference in the gap between Rfree and Rwork is not so evident 
(between 0.5 and 1.8%). SHELXL produces also a list file (.lst) where the trend of 
  Rwork(%) Rfree(%) Rfree-Rwork(%) 




old 20.93 32.64 11.71 232 245 W-His 
new 24.28 33.38 9.1 0 0 
old 18.28 30.11 11.83 65 3 Y53F new 22.09 28.06 5.97 0 0 
old 23.32 32.26 8.94 72 1 Y55K 
new 24.01 32.06 8.03 0 0 
old 14.98 23.73 8.75 580 25 AR 
new 19.36 24.10 4.74 95 1 
old 14.58 26.04 11.46 126 21 Con20 new 16.94 24.24 7.30 5 0 
old 14.98 23.73 8.75 121 20 C2A 
new 19.36 24.10 4.74 8 0 
old 19.61 28.24 8.63 299 58 Con17 
new 21.96 26.49 4.53 1 0 
old 15.86 26.67 10.81 44 3 Visc-a3 new 18.17 24.00 5.83 1 0 
old 18.46 27.44 8.98 37 0 Y53S 
new 21.57 27.17 5.60 0 0 
old 15.25 22.19 6.94 29 11 Thermo 
new 16.70 21.47 4.77 0 0 
old 12.1 17.6 5.5 190 36 Gi_ca new 13.4 17.1 3.7 14 0 
old 14.08 19.99 5.91 109 16 Thau 
new 14.14 19.49 5.35 17 0 
old 14.98 19.53 4.55 114 0 C2B 
new 16.80 19.93 3.13 3 0 
old 16.44 20.54 4.10 102 0 tPphA new 17.72 21.24 3.52 3 0 
 
Table 5.4 The different data sets used and jobs carried out with the corresponding Rfree, Rwork are 







refinement is stored together with other useful information. In this file are listed all the 
atoms that were flagged as "non positive definite" (NPD), which means that the atoms are 
described by an ellipsoid that has no physical sense. Using the old version all data sets 
except C2B, tPphA and Y53S got at least one atom NPD with the worst being W-His 
with 245 NPD atoms. On the contrary using the new version of the DELU restraint all 
atoms for all data sets behave well with just one NPD atom for the data set C2A. In this 
file are written out also atoms for which the anisotropic displacement parameters are 
quite big meaning that these atoms could be refined at more than one site. These atoms 
got flagged as "may be split". Using the old version of SHELXL at least 29 atoms per data 











































R  old free SHELXL
R  old work  SHELXL
R  new free SHELXL
R  new work SHELXL  
 
Figure 5.6 Graph that shows the results (Rwork and Rfree) obtained using the old and the new 







resolution (Con17) even 299 atoms out of 1874 were suggested to be refined at two sites. 
It seems that the new version of the DELU restraint improves also this parameter. Indeed 
an average of only 4.3 atoms per structure were flagged as "may be split". Thaumatin was 
the worst data set with 17 atoms that could be refined in double position. Con17 that was 
the worst with the old version instead got only one "may be split" warning.  
All these observations clearly show that the newly implemented DELU restraint works 


























5.4 Conclusion and perspectives 
A new version of SHELXL in which a new DELU restraint was implemented was 
tested. This new restraint mimics a TLS refinement and it should consequently be useful 
at medium resolution when a simply isotropic refinement is not satisfactory and a fully 
anisotropic refinement is not justifiable. Comparisons were made between TLS 
refinement as implemented in REFMAC and the new version of SHELXL and between 
two versions of SHELXL. The results show that at low resolution (worse than 2.0 Å) 
REFMAC works better than SHELXL while at medium resolution (1.6-2.0 Å) the results 
are comparable. The new implementation of DELU restraint, however, is a big 
improvement compare to the previous one. 
More tests have to be made to find the best values for the default parameters both for the 
distance between the atoms considered and for the estimated standard deviation that has 








Structure of the Aldose Reductase inhibitor IDD594 
 
Introduction 
IDD594 is an Aldose Reductase inhibitor that belongs to the carboxylic acid type classes. 
It has a good affinity in vitro but a low efficiency in vivo. Due to its low pka value, at 
physiological pH it is ionized and does not easily cross the membrane (Costantino et al. 
1999; Miyamoto 2002). The carboxylate group is necessary for efficient inhibition while 
the aromatic side chain is critical for both potency and selectivity. The structure to 0.66 Å 
of the complex of IDD594 with AR has been solved (PDB-ID: 1us0, (Howard et al. 
2004)). The structure of the inhibitor has been determined to 0.83 Å with the aim to use 
the data in further charge density studies to describe its electrostatic properties.  
 
Materials and methods 
The inhibitor IDD594 was dissolved in acetone and crystallized by slow solvent 
evaporation. Single yellowish crystals were obtained after one month. Data to 0.838 Å 
from a crystal of dimension 0.2x0.2x0.15 mm3 coated with paraffin oil were collected on 
a Stoe Image Plate IPDS-II system equipped with a Bruker AXS CCD detector using 
MoKα  radiation (λ = 0.71073 Å) at 133 K. Data were indexed, integrated and scaled with 
the Stoe program X-AREA. Data analysis and merging was performed with the Bruker 
program XPREP. The structure was solved by direct methods with the program SHELXD 
(Sheldrick 2004) and further refined against intensities with SHELXL (Sheldrick et al. 











The structure of the inhibitor IDD594 was determined to a resolution of 0.83 Å. It is 
characterized by a disordered Fluorine atom on the benzyl ring that has attached also a 
Bromine atom. When the Fluorine is bound to C27 has an occupancy of 80.2 % and when 
it is bound to C26 is occupancy is 19.8% (Fig. AppA_1A). Two molecules of the 
inhibitor are coupled by hydrogen bonds between the two carboxylic heads (Fig. 
AppA_1B). Bond lengths and bond angles are listed in Tables B/C respectively. 
Chemical formula C16H12BrF2NO3S 
Space group P-1 
Unit cell parameters (Å, °) 
a = 10.740(2), b = 12.006(2), c = 13.180(3); 
α = 77.75(3), β = 69.08(3), γ = 82.81 (3) 
Volume (Å3) 1549.04 
Z 4 
Crystal size (mm) 0.20 x 0.20 x 0.15 
Dx (mg/m3) 1.785 
Absorption coefficient (mm-1) 2.826 
F(000) 832 
Reflections collected 23262 
Independent reflections (I  > 2σ) 5335 
Rint §(%) 7.79 
Mean (I / σ) 16.2 
Θ range (°) 1.68 - 24.86 
Data/restraints/parameters 5335/0/451 
Goodness of fit on F2 1.050 
R1 (%) ( I > 2σ(I)) 4.31 
Largest diff. peak/hole 0.463/ -0.628 
 
Table A Data and refinement statistics for inhibitor IDD594 (§ ( )∑ ∑−= I/IIR int ; 








The structure of the inhibitor was compared to the one of IDD594 in the crystal structure 
of the complex with AR refined to a resolution of 0.66 Å (Fig. AppA_2). The largest 
difference between the two structures is the protonation state of the carboxylic head: the 
isolated inhibitor is protonated as it can been seen both from the hydrogen bond and from 
the oxygen carbon distances (O33A...C32A = 1.233 Å, O34A...C32A = 1.291 Å) while in 
the complex with AR it is negatively charged (O33...C32 = 1.23(9) Å and O34...C32 = 
1.26(2) Å).The orientation of the carboxylic head is different in the two structures due to 
diverse modes of interaction with surrounding atoms. Also the mutual orientation of the 
aromatic rings is different in the two structures. The distance between Br8 and C25 is 











Figure AppA_1. A) Monomer of the inhibitor IDD594. B) Dymer stabilized by hydrogen bonds 
























Figure AppA_2 Superposition of inhibitor IDD594 in the isolated structure (Carbon atoms 
depicted in cyan) and in the complex with Aldose Reductase (Carbon atoms depicted in green). 
Bromines are drawn in magenta, Fluorines in orange, Sulfurs in yellow, Nitrogens in blue and 







Molecule A  Molecule B 
Br(8A)-C(25A)  1.890(4) 
S(16A)-C(11A)  1.684(4) 
F(9A)-C(5A)  1.358(4) 
O(34A)-C(32A)  1.233(5) 
O(15A)-C(4A)  1.376(5) 
O(15A)-C(20A)  1.427(5) 
O(33A)-C(32A)  1.291(5) 
C(5A)-C(6A)  1.371(6) 
C(5A)-C(2A)  1.374(6) 
F(14)-C(26A)  1.331(5) 
F(14')-C(27A)  1.276(13) 
C(4A)-C(2A)  1.398(5) 
C(4A)-C(7A)  1.405(6) 
N(17A)-C(11A)  1.329(5) 
N(17A)-C(13)  1.472(5) 
C(11A)-C(7A)  1.503(5) 
C(25A)-C(29A)  1.380(6) 
C(25A)-C(28A)  1.389(6) 
C(28A)-C(26A)  1.380(6) 
C(7A)-C(3A)  1.397(6) 
C(6A)-C(3A)  1.385(6) 
C(32A)-C(20A)  1.498(5) 
C(24A)-C(26A)  1.382(7) 
C(24A)-C(27A)  1.388(6) 
C(24A)-C(13)  1.501(6) 



























Br(8B)-C(25B)  1.887(4) 
S(16B)-C(11B)  1.667(4) 
F(9B)-C(5B)  1.357(5) 
O(34B)-C(32B)  1.221(5) 
O(15B)-C(4B)  1.367(5) 
O(15B)-C(20B)  1.423(5) 
O(33B)-C(32B)  1.300(5) 
C(6B)-C(5B)  1.368(6) 
C(5B)-C(2B)  1.377(6) 
 
F(14B)-C(27B)  1.368(5) 
C(2B)-C(4B)  1.392(5) 
C(4B)-C(7B)  1.414(6) 
N(17B)-C(11B)  1.324(5) 
N(17B)-C(13B)  1.465(5) 
C(11B)-C(7B)  1.515(5) 
C(25B)-C(29B)  1.377(6) 
C(25B)-C(28B)  1.391(6) 
C(28B)-C(27B)  1.384(6) 
C(3B)-C(7B)  1.394(6) 
C(6B)-C(3B)  1.391(6) 
C(32B)-C(20B)  1.509(5) 
C(24B)-C(26B)  1.399(6) 
C(24B)-C(27B)  1.384(6) 
C(24B)-C(13B)  1.502(6) 
C(29B)-C(26B)  1.391(6) 









 Table C Bond angles (°) of isolated IDD594

















































































































Free variables used in the refinement of Aldose Reductase 
 
FVAR occupancy main conformation (%) Residue Atoms 
2 58.3 E126 side chain 








5 89.8 L104 side chain 
6 72.7 P117 side chain 
7 50.5 P132 all 
































9 51.5 H163 all 
10 71.3 M168 side chain 
11 53.1 I169 side chain 
12 94.4 L175 all 



















FVAR occupancy main conformation (%) Residue Atoms 
15 33.0 E279 side chain 
16 64.4 S282 side chain 
17 80.5 T244 side chain 
18 96.3 T243 side chain 













21 55.3 M2001 all 






23 55.8 K116 
HOH4008 
side chain 
24 73.8 E64 all 
25 58.3 I152 side chain 
26 68.2 K154 side chain 
27 53.2 P179 CG 
28 72.1 E193 
HOH4015 
side chain 
29 81.1 K202 side chain 






31 63.6 K239 side chain 
































FVAR occupancy main conformation (%) Residue Atoms 
















37 59.9 E60 
HOH4032 
side chain 
38 53.4 Q197 
HOH4012 
side chain 
39 66.2 N241 side chain 
40 58.3 I15 all 




42 56.5 K119 side chain 

















44 79.6 E271 
HOH4007 
side chain 












List of disagreeable restraints 
 




List of angle distance (DANG) disagreeable restraints longer than 5 sigma 
 
 
Observed Target Δ (Deviation) Δ / σ Atoms 
1.9598 2.1000 -0.1402 7.01 HD2B_136a H0_139 
1.9691 2.1000 -0.1309 6.55 H0A_84b HG3_84b 
3.1699 3.3000 -0.1301 6.50 C_197 CD_197b 
3.1762 3.3000 -0.1238 6.16 C_76 CG_77 
3.1850 3.3000 -0.1150 5.75 C_209 CD1_209 
2.6861 2.8000 -0.1139 5.69 O_299 C_300 
1.9865 2.1000 -0.1135 5.67 HG1C_66 HG2_132a 
3.1927 3.3000 -0.1073 5.32 CD1_209 C17_318 
Observed Target Δ (Deviation) Δ / σ Atoms 
2.0940 2.4350 -0.3410 7.12 C_136a CA_137a 
2.0370 2.3690 -0.3320 7.14 C3_321a O5_321a 
2.7994 2.5100 0.2894 7.23 CG_194a CE_194a 
2.2383 2.5260 -0.2877 7.14 CB_84b CD_84b 
2.1516 2.4350 -0.2834 7.08 C_215 CA_216b 
2.8430 2.5590 0.2840 7.10 CA_126 CG_126a 
2.7913 2.5100 0.2813 7.04 CB_194a CD_194a 
2.7538 2.4790 0.2748 6.85 N_137b CB_137b 
2.2060 2.4790 -0.2730 6.82 N_137a CB_137a 
2.1887 2.4550 -0.2663 6.66 CB_129b N_129b 
2.6350 2.3730 0.2620 6.55 OG1_135a CG2_135a 
2.1376 2.3950 -0.2574 6.39 C6_321a O7_321a 
2.2508 2.5040 -0.2532 6.34 CG1_67b CG2_67b 
2.6616 2.4350 0.2266 5.66 C_222a CA_223a 
2.6419 2.4250 0.2169 5.40 CA_305b N_306 
2.7740 2.5590 0.2150 5.37 CA_223a CG_223a 
2.3665 2.5760 -0.2095 5.23 CA_169 CG1_169a 
2.7018 2.4930 0.2088 5.22 CD_221a NZ_221a 
2.5869 2.3790 0.2079 5.14 CG_70a OE1_70a 






















Δ (Deviation) Δ / σ Atoms 
1.7270 17.23 CB_209 CD1_209 CE2_209 OH_209  etc 
0.9871 9.87 CB_39 CD1_39 CE2_39 OH_39  etc. 
0.9540 9.54 CB_79 CE2_79 CZ3_79 CG_79 
0.8539 8.54 CB_107 CD1_107 CE2_107 OH_107  etc. 
0.7579 7.58 CB_48 CD1_48 CE2_48 OH_48 etc. 
0.5945 5.94 CD_255 NH1_255 NH2_255 NE_255 
0.5709 5.71 CD_69 NH1_69 NH2_69 NE_69 
Δ (Deviation) Δ / σ Atoms 
1.9509 3.90 O_132 CA_132 N_133a CA_133a 
1.9175 3.83 O_181 CA_181 N_182 CA_182 
1.7576 3.51 O_108 CA_108 N_109 CA_109 
1.7205 3.44 O_132 CA_132 N_133b CA_133b 
1.6890 3.38 O_276b CA_276b N_277b CA_277b 
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Observed Target Δ (Deviation) Δ / σ Atoms 
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List of distance (DFIX) disagreeable restraints longer or shorter than 3 sigma 
 
Observed Target Δ (Deviation) Δ / σ Atoms 
1.1512 1.2490 -0.0978 -4.89 CD_150a OE2_150a 
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1.3990 1.4600 -0.0610 -3.05 CD_40b NE_40b 
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